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1 Abstract 
γδ T cells are a rare subset of T cells present in human blood and lymphoid tissues. 
Functionally, they stand at the interface of the innate and the acquired branch of the 
immune system as they express somatically rearranged antigen receptors but they also share 
many characteristics with NK cells. One of those is the ability to express CD16. CD16 is a 
cell-surface receptor that binds the Fc portion of IgG. In the isoform found on tissue 
macrophages and NK cells it is coupled to an intracellular signalling domain that allows it 
to initiate cellular processes leading to the internalisation of IgG-coated particles or 
cytotoxicity against IgG-coated cells. Therefore, it has a role in the clearance of IgG-coated 
complexes and the destruction of infected or malignant cells. In this thesis, I show that a 
population of γδ T cells present in human blood from healthy donors express the CD16 
receptor and implicate a role for this receptor in phagocytosis of IgG-coated bacteria and 
synthetic beads coated with recombinant influenza M1 protein. These cells were 
subsequently shown to activate influenza-specific T cells through MHC II presentation. 
Importantly, neither αβ T cells nor NK cells were capable of significant phagocytosis. In 
addition, once CD11c+ cells had been removed from the NK fraction, neither αβ T cells 
or NK cells were capable of MHC II antigen presentation of influenza M1 antigen. The 
CD16+ γδ T cells displayed a phenotype of effector memory and late effector memory T 
cells suggesting a role for these cells in patrolling the blood and rapidly migrating to sites 
of inflammation for a combination of rapid effector and antigen presentation function. 
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2 Introduction 
Millions of years of co-habitation with microorganisms have generated formidable 
defences against infection. The first line of defence against human pathogens are the 
physical and chemical barriers that separate us from the outside world, that is, the linings 
of the skin, the enzymes in our tears and saliva, the acidic pH in our stomach. These 
defensive barriers are evolutionarily very ancient and provide us with protection against a 
broad and largely unforeseen spectrum of pathogens. When a pathogen breaches these first 
lines of defence, the cells of the innate immune system come into play. Macrophages are 
cells of the innate immune system and reside in tissues. They have receptors on their 
surface that recognise common patterns found on the bacterial surface called pathogen-
associated molecular patterns (PAMPs). They use these receptors to bind and engulf and 
then destroy these microorganisms. Macrophages activated by pathogen products produce 
soluble mediators called cytokines that recruit other cells of the immune system from the 
blood stream, notably neutrophils and immature dendritic cells. When at the site of injury, 
neutrophils quickly engulf and destroy large amounts of bacteria. Immature dendritic cells, 
however, process the pathogen intracellularly into smaller pieces, called antigens. They then 
display these on their cell surface on specific receptors called MHC molecules. Antigens 
displayed on MHC class I and MHC class II molecules activate CD8 and CD4 T cells, 
respectively. These cells are part of the adaptive branch of the immune system, that 
appeared later in evolutionary terms, and added an enormous diversity to the types of 
pathogens to which the organism could be protected from. In addition, adaptive immunity 
included a method by which the organism can learn from previous infections, and generate 
a faster and stronger immune response against a second infection with the same pathogen. 
In this introduction I will detail the mechanisms by which cells of the immune system use 
phagocytosis, cytotoxicity and antigen presentation to control infection. Afterwards, I will 
describe human γδ T cells and what is known about them in these fields. 
2.1 Phagocytosis 
The mechanisms of recognition, uptake and degradation of particles by professional 
phagocytes have been thoroughly reviewed recently by Flannagan and Jaumouille et al (1). 
Cells of the immune system use phagocytosis to clear pathogens like bacteria or fungi from 
a site of infection. It is also important for the engulfment of apoptotic bodies which is 
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crucial for tissue homeostasis and remodelling. Phagocytosis was first observed by Elias 
Metschnikoff more than a century ago (2) and is defined as the ingestion of relatively large 
(≥ 0.5 µm) particles by a process that is both receptor-mediated and actin-dependent. 
Unlike macropinocytosis, it involves the recognition and binding of particles by specific 
receptors on the surface of the phagocytic cell. Although there are different phagocytic 
receptors as well as different cells capable of phagocytosis, there are key principles that 
govern all phagocytic processes. These key principles are the requirement for a coordinated 
signalling cascade induced by particle binding, the need for cytoskeletal rearrangement and 
the occurrence of membrane remodelling (1).  
Phagocytosis is mostly performed by macrophages and neutrophils. Also part of the 
myeloid phagocyte system are inflammatory monocytes and immature dendritic cells (3). 
Macrophages mature continuously from monocytes in the bloodstream that migrate into 
tissues and become tissue resident macrophages. Neutrophils are polymorphonucleated 
cells (PMN) that are abundant in the blood but short-lived. They make up the vast majority 
(around 70%) of leukocytes, or white blood cells, in human blood. Macrophages are the 
first to encounter a pathogen because they are usually present at the site of infection, but 
they are soon met by neutrophil reinforcements. Phagocytes recognise pathogens by means 
of their cell-surface receptors and can discriminate between host and pathogen surface 
markers. 
Phagocytic receptors include receptors that recognise foreign bodies and receptors that 
recognise apoptotic bodies. Pathogens often display molecules not found in the host cells. 
These are called pathogen-associated molecular patterns (PAMPs) and can be detected by 
several receptors, in particular Toll-like receptors (TLRs) but also some phagocytic 
receptors. Table 1 lists phagocytic receptors that recognise pathogens and are found in 
human phagocytes. For instance, the lipopolysaccharide (LPS) displayed by gram-negative 
bacteria is detected by the scavenger receptor A (4). Pathogens can also be recognised 
indirectly through soluble molecules that coat them and are found in circulation in the 
blood and interstitial fluids. These molecules are called opsonins and include 
immunoglobulins and components of the complement cascade. The best characterised 
opsonic receptors bind the Fc portion of immunoglobulin G (IgG) (5) or the complement 
component iC3b (6). Receptors for apoptotic bodies, on the other hand, usually recognise 
17 
 
phosphatidylserine exposed on the surface of apoptotic cells. This lipid is usually restricted 
to the inner leaflet of the plasma membrane in healthy cells and is therefore not detected 
by phagocytes (7-9). 
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Table 1 – Human receptors mediating phagocytosis of pathogens, and their ligands 
Adapted from Flannagan RS, Jaumouille V, Grinstein S. The cell biology of phagocytosis. Annu 
Rev Pathol 2012;7:61-98.  
Receptors Ligands References 
Pattern-recognition 
receptors 
  
Mannose receptor (CD206) Mannan (10) 
Dectin-1 (CLEC7A) β1,3-glucan (11) 
CD14 Lipopolysaccharide-binding protein (12) 
Scavenger receptor A 
(CD104) 
Lipopolysaccharide, lipoteichoic acid (4;13) 
CD36 Plasmodium falciparum-infected 
erythrocytes 
(14) 
MARCO Bacteria (15) 
Opsonic receptors   
FcγRI (CD64) IgG1 = IgG3 > IgG4 (5) 
FcγRIIa (CD32a) IgG3 ≥ IgG1 = IgG2 (5) 
FcγRIIIa (CD16a) IgG (5) 
FcαRI (CD89) IgA1, IgA2 (16) 
FcεRI IgE (17) 
CR1 (CD45) Mannan-binding lectin, C1q, C4b, C3b (18) 
CR3 (αMβ2, CD11b/CD18, 
Mac-1) 
iC3b (6) 
CR4 (αVβ2, CD11c/CD18, 
gp150/95) 
iC3b (6) 
α5β1 Fibronectin, vitronectin (19) 
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Recognition of pathogens through phagocytic receptors is just the first step in 
phagocytosis. Receptor binding leads to the activation of intracellular signalling cascades. 
The best-understood model is the internalisation of IgG coated particles by Fcγ receptor-
mediated phagocytosis in macrophages. In conceptual terms, the process takes three 
consecutive steps. First the Fcγ receptors bind the IgG coated particle. Then the Fcγ 
receptors cluster together triggering an intracellular signalling cascade. The signalling 
cascade drives actin polymerisation and the engulfment of the particle. 
Clustering of the Fcγ receptors brings the cytosolic domain of these receptors in close 
proximity. The receptors contains a region called immunoreceptor tyrosine-based 
activation motif (ITAM). Receptor clustering leads to phosphorylation of tyrosines in 
ITAM motifs by tyrosine kinases, particularly of the Src family. Receptor phosphorylation 
is followed by the recruitment of adaptor proteins and the resulting signalling cascade 
activates the actin nucleation complex Arp2/3 which elicits actin polymerization and drives 
the extension of pseudopods that surround the foreign particle. Arp2/3 supports actin 
polymerization in Fcγ receptor-mediated phagocytosis (20). It can be activated by Wiskott-
Aldrich syndrome protein (WASP). In fact, macrophages from patients with Wiskott-
Aldrich syndrome, that have defective WASP, show impaired Fcγ receptor-mediated 
phagocytosis (21). 
Although there are differences between the mechanisms of action of different phagocytic 
receptors, all receptor-mediated phagocytosis involves the engulfment of the particle in a 
membrane-bound vacuole called the phagosome. Once inside the cell, the phagocyte can 
manipulate the conditions inside the phagosome to promote the destruction of the trapped 
organism. Conversely, some pathogens have evolved remarkable strategies to manipulate 
phagosome maturation. A notable example is Mycobacterium tuberculosis, the causative agent 
of human tuberculosis. Once inside the macrophage phagosome, Mycobacterium tuberculosis 
arrests phagosome maturation at an early stage where it can survive inside the host (22). In 
normal settings, the phagosome interacts in succession with various endocytic 
compartments, to generate vacuoles of increasingly microbicidal power. As a result, the 
mature phagosome is markedly acidic (pH ≈ 4.5), highly oxidative and enriched with 
hydrolytic enzymes that all contribute to the destruction of the particle. 
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Of note, phagosome maturation is different in dendritic cells and in neutrophils and 
macrophages. Although neutrophils and macrophages primarily serve to destroy the 
pathogen, the main function of dendritic cells (DCs) is to activate primary and secondary 
adaptive immune responses. The initiation of adaptive immune responses requires CD4 
and CD8 T cells to recognise short peptides associated with MHC class II or class I 
molecules present on the surface of DCs. For this reason, it makes sense that the pH in 
the phagosome in dendritic cells remains neutral throughout phagosome maturation since 
this could promote the recovery of a variety of different antigens from an engulfed body, 
as opposed to its quick degradation (23). 
The unique microbicidal and degradative capacities of the mature phagosome are the result 
of the concerted effort of not only its acidic pH, but the presence of hydrolytic enzymes, 
oxidants and cationic peptides, acquired through the earlier fusion with lysosomal vesicles. 
The low pH is also required to activate lysosomal hydrolases such as cathepsins that 
function optimally in acidic conditions. However, the various contributions of the different 
lytic effector mechanisms is, as mentioned earlier, variable among the different types of 
phagocytes, depending on their primary function. In neutrophils, the fusion with endocytic 
vesicles is replaced by fusion with neutrophil granules that carry multiple antimicrobial 
molecules. Some of these molecules are specific to neutrophils, such as the antibiotic 
peptides of the defensin and cathelicidin families (24). Phagocytosis induces a respiratory 
burst where reactive oxygen species are produced that help destroy the pathogen. 
Neutrophils are particularly strong at producing reactive oxygen species (ROS)  (25). The 
most important of these are nitric oxide (NO), the superoxide anion (O2-) and hydrogen 
peroxide (H2O2) which are toxic to bacteria. Nitric oxide is produced by the nitric oxide 
synthase iNOS2. Superoxide is generated through the NADPH oxidase complex. 
Mutations affecting genes encoding subunits of the NADPH oxidase complex in chronic 
granulomatous disease (CGD) lead to impairment of ROS production and patients suffer 
from recurrent infections by numerous bacterial and fungal pathogens (26). 
Phagocytosis ultimately culminates in the destruction of the internalised pathogen. 
Subsequently, antigens recovered from the digested pathogen can be presented by antigen 
presenting cells to activate CD4 and CD8 T cells and initiate an adaptive immune response. 
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2.2 Cell-mediated cytotoxicity 
The extracellular milieu is a particular inhospitable place for a pathogen and many of them 
have chosen to infect the cells of the host. In addition, cells of the host can turn cancerous. 
These cells will need to be removed in order to control infection and prevent the 
development of a tumour. The mechanisms by which cells of the immune system destroy 
infected or “altered” cells generally involve either a granule exocytosis pathway or a “death 
receptor” pathway. The recognition process that initiates these events depends on the 
nature of the effector cell. It can be divided into TCR-mediated recognition, Fas/Fas ligand 
recognition or recognition by Natural Killer (NK) receptors, although cells other than NK 
cells can express “NK receptors” particularly γδ T cells and activated CD8 T cells as 
recently reviewed (27). Recognition of the infected or tumour cell can also occur in an 
indirect manner, through antibodies bound to its cell surface and Fc receptors on the 
surface of the effector cell. Cellular effectors of antibody-dependent cytotoxicity (ADCC) 
are NK cells, γδ T cells, activated CD8 T cells, monocytes, macrophages and dendritic cells. 
Neutrophils and eosinophils can also mediate ADCC but require cytokine activation. 
A glimpse of the receptor-ligand interactions that can activate cytotoxicity is shown in 
Table 2. These receptors bind to and are activated by molecules expressed on the surface 
of infected or distressed cells. NK cells quickly recognise and respond to targets via 
germline encoded receptors. Activating receptors present in NK cells include the Fcγ 
receptor CD16, NKG2D, and the natural cytotoxicity receptors NKp30, NKp44 and 
NKp46, as well as many others (28). The activation of NK cell cytotoxicity is the 
consequence of the integration of signals from both the activating and inhibitory receptors 
(29). Inhibitory receptors recognise MHC class I molecules, expressed by all cells of the 
body except erythrocytes. Therefore, engagement of MHC class I molecules by NK cell 
receptors leads to an inhibitory signal that prevents the NK cell from being activated and 
spares the healthy cell from being killed. However, many tumour cells downregulate MHC 
class I molecules and in the absence of inhibitory signals the NK cell will become activated 
and kill the target. Even activating receptors can be manipulated by the pathogen to prevent 
NK cell activation. Human cytomegalovirus (CMV) for instance encodes proteins that 
mimic MHC class I and bind the NK cell inhibitory receptor, LIR-1, with a higher affinity 
than host MHC class I, and proteins that decrease the expression of CD155, a ligand for 
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NK cell activating receptors (30). The CMV main tegument protein pp65 can also inhibit 
NK cell activation via binding to NKp30 (31). Similarly, the proliferating cell nuclear 
antigen (PCNA) which is overexpressed by cancer cells, binds to and inhibits NKp44 (32). 
Finally, NKG2D, expressed by NK cells, γδ T cells and CD8 T cells, recognises the stress 
ligands MHC-class-I chain-related molecules A and B (MICA/B) and UL16-binding 
proteins leading to an activation signal. 
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Table 2 – Selected ligands and human receptors capable of inducing cell-mediated cytotoxicity 
Receptors Ligands Source References 
CD8 – TCR 
complex 
MHC class I – peptide complex All types of 
pathogen-
derived protein 
antigens 
(33) 
Fas / CD95 Fas ligand Various cell 
types 
(34) 
NKG2D MICA, MICB and UL16-
binding proteins (ULBPs) 
Stressed cells (35) 
NKp30 Plasmodium falciparum erythrocyte 
binding protein (PfEMP-1) 
 
Human leukocyte antigen B-
associated transcript 3 (BAT3) 
Plasmodium 
falciparum 
infected cells 
Tumour cells 
(36) 
 
 
(37) 
 
 
 
NKp44 Viral haemagglutinins Virus infected 
cells 
(38) 
NKp46 Hemagglutinin (HA) proteins 
of the influenza and vaccinia 
virus 
Vimentin 
Virus infected 
cells 
 
Mycobacterium 
tuberculosis 
infected cells 
(38;39) 
 
(40) 
Fc receptors IgG, IgA and IgE bound 
particles 
Antibody-coated 
target cells 
(41) 
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CD8 T cells, or cytotoxic T cells, are able to recognise an incredible variety of antigens via 
their T cell receptor (TCR). This recognition is stabilised by the interaction between CD8 
on the cytotoxic T cell and MHC class I expressed on the target cell. The MHC class I 
complex presents foreign proteins derived from antigen processing. A second signal is 
provided by CD28 engagement on the cytotoxic T cell by CD80 or CD86 on the antigen 
presenting cell. The enormous repertoire of antigens recognised by T cells is due to the 
evolution of a process called V(D)J recombination where V, D and J gene segments are 
somatically rearranged to construct an immense diversity of possible T cell receptors from 
the same set of genes. Each T cell will express only one of these possible combinations in 
their TCR and will expand when their specific antigen is encountered during the course of 
an immune response. 
Another way by which cell death can be induced is through Fas – Fas ligand interactions. 
Fas can be upregulated in various immune and non-immune cells and its engagement leads 
to the induction of programmed cell death, or apoptosis, in the target cell. It is particularly 
important in the resolution of an immune response, as Fas – Fas ligand interactions are 
used to eliminate T cells that have expanded during the course of the immune response 
but that are no longer necessary. The importance of the FAS pathway in the regulation of 
the immune response is evident by the autoimmunity caused by genetic defects in the FAS 
gene in severe autoimmune lymphoproliferative syndrome (ALPS) (42;43). 
Last but not least, cell-mediated cytotoxicity can be induced indirectly by the binding of Fc 
receptors on the effector cell with the Fc portion of an antibody-coated target cell. This 
process is called antibody-dependent cytotoxicity (ADCC). When target bound antibodies 
crosslink activating Fc receptors, a cytotoxic pathway is initiated. Therefore, the specificity 
of ADCC is conferred by target-bound antibody which means monoclonal antibody 
therapy may be an attractive option for cancers over-expressing specific antigens (44). The 
main effector cells for ADCC are NK cells although other Fc receptor-expressing cells can 
mediate ADCC. The role of ADCC in host immunity is strongly highlighted by the impact 
of Fcγ receptor polymorphisms on the clinical outcome of cancer patients. The Fcγ 
receptor IIIA, or CD16A, is expressed by NK cells, γδ T cells, activated αβ T cells and 
macrophages. The CD16A gene exhibits a polymorphism due to a single nucleotide change 
leading to the presence of either a valine or a phenylalanine at position 158. The presence 
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of a 158V genotype results in a stronger binding to human IgG1 and has been associated 
with a better outcome in non-Hodgkin lymphomas treated with the anti-CD20 IgG1 
antibody rituximab (45;46). 
Although the manner in which cytotoxic responses are activated by different effectors may 
be different, owing to the different receptors expressed, two common cytotoxicity methods 
are shared: the granule exocytosis pathway and the Fas pathway. The granule exocytosis 
pathway utilizes perforin to traffic granzymes to appropriate locations in the target cells, 
where they cleave critical substrates that initiate DNA fragmentation and apoptosis. This 
is mediated by a calcium-dependent polarised exocytotic process at the lytic synapse. The 
lytic synapse involves the reorganisation of the actin cytoskeleton and the clustering of 
membrane receptors at the site of contact with the target cell. Perforin, released from 
granules in the effector cell, inserts and polymerises within the target cell membrane, 
allowing access of granzymes to the target cell cytosol. The importance of perforin is 
highlighted by the severe immunodeficiency caused by the lack of a functional perforin 
gene that predisposes a child to overwhelming viral infection in familial hemophagocytic 
lymphohistiocytosis type 2 (47). In addition, crosslinking of the Fc receptor CD16 on NK 
cells induces the expression of Fas ligand, enabling them to kill Fas+ targets. Therefore, 
the two cytotoxicity pathways can be used by the same cell to mediate killing of targets. 
2.3 Antigen presentation 
Innate cells are involved in the induction of adaptive immune responses. Microbial antigens 
typically enter through the skin and gastrointestinal tracts, where they are captured by 
dendritic cells (DCs) and trafficked into afferent lymph nodes. At the lymph node, the 
dendritic cell encounters T cells and specifically activates them via TCR-MHC interactions 
and co-stimulation. Alternatively, antigens that enter the blood stream are captured by 
antigen presenting cells in the spleen. When a dendritic cell takes up a pathogen, it becomes 
activated, and matures into a highly effective antigen presenting cell (33). Maturation leads 
to downregulation of phagocytic receptors like Fc receptors and mannose receptors. 
Conversely, maturing dendritic cells upregulate molecules related to T cell activation, 
including the co-stimulation molecules CD80, CD86 and ICAM-1 and the cytokine IL-12, 
and increase both the number of MHC class II molecules on their cell surface and their 
half-life (48). 
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The three major types of antigen-presenting cells are dendritic cells, macrophages and B 
cells. Antigen presentation by mature dendritic cells at peripheral lymphoid organs leads to 
the activation of naïve T cells, i.e., T cells that have never encountered antigen before. 
Activation induces clonal expansion and differentiation into effector T cells. Effector T 
cells combat the infection by producing cytokines that activate other cells or by cell-
mediated cytotoxicity. These are mainly CD4 T cells and CD8 T cells, respectively. In 
particular, inflammatory CD4 T cells activate macrophages to destroy phagocytosed 
microbes through the production of IFN-γ and interactions of CD40 ligand (CD40L) 
expressed on their surface with CD40 on the macrophage. In addition, they also play an 
important role in stimulating antibody production by B cells that recognise the same 
antigen by providing a second signal with CD40-CD40L interactions when they recognise 
a specific peptide-MHC complex presented on the B cell surface. This leads to the 
proliferation and differentiation of B cells into antibody-producing plasma cells. An 
alternative co-stimulation signal can be provided by common microbial constituents like 
bacterial polysaccharides encountered by the B cell, in the absence of T cells. 
Peptides can be presented on MHC class I molecules or on MHC class II molecules, and 
are recognised by CD4 T cells or CD8 T cells, respectively. Peptides can originate from 
different sources, intracellular for MHC class I or exogenous for MHC class II. In addition, 
cross-presentation can also occur where exogenous antigen is presented by MHC class I 
molecules. In this way, exogenous antigen can also prime CD8 T cells. This circumvents a 
conceptual problem with naïve T cell activation. Naïve T cells, whether CD4+ or CD8+, 
need to be activated by professional APCs, usually dendritic cells. In the case where a 
pathogen does not infect APCs or interferes with its MHC class I pathway, or even when 
a tumour arises in a non-APC cell type, naïve CD8 T cells would not be activated to exert 
their cytotoxic function. Cross-presentation circumvents these problems by allowing 
antigen acquired exogenously, such as in the form of infected cell debris, to be presented 
on MHC class I allowing the priming of CD8 adaptive immunity (49). In addition, 
endogenous proteins can be presented on MHC class II when they are degraded by 
autophagy (50). Autophagy is a process used during cellular homeostasis to salvage amino 
acids from proteins and organelles at the end of their life. 
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MHC class I molecules are expressed by all nucleated cells. In MHC class I presentation, 
antigens are degraded by cytosolic and nuclear proteasomes. The resulting peptides are 
translocated into the endoplasmic reticulum (ER) by transporter associated with antigen 
presentation (TAP). In the ER, peptide and MHC class I molecules are assembled and the 
complexes leave for expression at the cell surface (51).  MHC class II molecules are 
encoded by three polymorphic genes (HLA-DR, HLA-DQ and HLA-DP in humans) that 
bind to different peptides. Many MHC class II alleles are strong genetic markers for several 
autoimmune disorders like rheumatoid arthritis, multiple sclerosis and type 1 diabetes 
although the mechanisms underlying the association are not clearly understood (52). MHC 
class II molecules are primarily expressed by professional antigen presenting cells (APCs) 
such as DCs, macrophages and B cells. The transmembrane α and β chains of MHC class 
II are assembled in the ER and associate with the invariant chain (Ii). The resulting complex 
is transported into a late endosomal compartment where Ii is digested, leaving a residual 
class II-associated peptide (CLIP) in the peptide-binding groove. CLIP is then exchanged 
for a peptide derived from antigen processing and the loaded MHC class II molecule is 
transported to the cell membrane for presentation to CD4 T cells. 
2.4 γδ T cells 
γδ T cells are non-conγentional T cells characterised by the presence of a CD3/TCR 
complex composed of γ and δ γariable chains, instead of α and β chains. Their 
serendipitous discovery dates back to the first attempts at cloning the αβ TCR in 1984 (53). 
In humans, they are present mainly in peripheral blood and in gut epithelia and small 
numbers of γδ T cells can also be found in the spleen and in the liver (54). In human blood, 
they typically make up to 5% of the total T cell pool whereas in the gut they constitute 25-
60% of total intraepithelial lymphocytes (IELs). γδ T cells in human and primate blood 
typically express the Vγ9Vδ2 TCR whereas tissue-associated γδ T cells are mostly Vδ1+ 
with Vδ3+ a smaller additional population. In mice, γδ TCR+ IELs are common in the 
skin where they are part of the dendritic epidermal T cell (DETC) compartment. Mouse 
γδ T cells seem to preferentially locate to body surfaces in contact with the outside world 
and are common in the tongue, the gut, the genital tract and the lung. 
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2.4.1 γδ TCR antigen recognition 
The γδ TCR, similarly to the αβ TCR and the immunoglobulin chains (Igs) of the B cell 
receptor (BCR) is generated through somatic rearrangement of V(D)J genes. V(D)J 
recombination generates antigen receptor diversity. However, γδ TCRs differ from αβ 
TCRs in the mechanism of antigen recognition and some respond to unique antigens. 
Unlike most αβ TCRs, γδ TCRs are not restricted to engaging a peptide presented on an 
MHC molecule. Structural clues suggest in fact that γδ TCRs may be more similar to Igs 
than to αβ TCRs in the way that they bind antigen, which could explain why they can 
respond to antigen in the absence of an antigen presenting molecule. The CDR3 loops 
(complementarity determining region 3) of the TCR α and β chain are nearly identical in 
length and their length is constrained. This generates a 3-dimensional structure which binds 
both peptide and MHC molecule on an antigen presenting cell. However, the CDR3s of 
Ig heavy chains are long and variable, and those of Ig light chains are short and constrained 
which allow B cells to recognise a variety of antigens without the need for an antigen 
presenting molecule. Similarly, the CDR3 length of the TCR δ chain is also long and 
variable whereas that of the TCR γ chain is short and constrained (55). Therefore, the 
predicted structure of the antigen binding moiety, suggests that γδ TCR-antigen 
interactions may be more similar to antibody-antigen interactions than αβ TCR-
peptide/MHC complex interactions. 
In contrast to αβ T cells, and in agreement with predicted Ig-like recognition by the γδ 
TCR, γδ T cells are generally double negative for both CD4 and CD8 and accordingly are 
not restricted by either MHC class II or MHC class I molecules in their ability to recognise 
their cognate antigen (56). Human and murine γδ TCRs are activated by a variety of 
molecules, including peptides, lipids, small phosphorylated prenyl metabolites and large 
protein antigens. These antigens have been recently reviewed by Chien et al (57) and are 
listed in Table 3.  
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Table 3 – γδ TCR ligands in man and mouse 
Adapted from Chien Y et al (57) and Vantourout P et al (58) 
Antigen γδ subset Context References 
Human γδ T cells    
MICA/B Vδ1 Stress-induced ligands expressed on 
intestinal epithelium and epithelial 
tumours 
(59;60) 
ULBP4 Vδ2 Stress-induced ligand expressed by 
tumour cells 
(61) 
CD1c Vδ1 (clones) CD1c expressed by APCs, 
upregulation of CD1c in the absence 
of foreign antigen could be a danger 
signal 
(62) 
CD1d-sulfatide Vδ1  Myelin glycosphingolipid, relevant in 
multiple sclerosis (MS) pathology 
(63) 
Endothelial protein 
C receptor 
Vγ4Vδ5 
(clone) 
Recognition of CMV-infected 
endothelial cells and epithelial 
tumours 
(64) 
Phycoerythrin (PE) 0.025% of γδ 
T cells 
Microbial recognition (65) 
Phosphoantigens Vγ9Vδ2 Broad recognition of tumours, 
bacteria and protozoa parasites 
(66) 
Histidyl-tRNA 
synthetase 
Vγ1.3Vδ2 Muscle infiltrating γδ T cells in 
autoimmune myositis patient  
(67) 
Listeriolysin O PBMC γδ T 
cells (clone) 
Recognition of bacterium-derived 
toxins 
(68) 
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Antigen γδ subset Context References 
Mouse γδ T cells     
T10/T22 0.1-1% of γδ 
T cells 
Recognition of infected lymphocytes 
with an activation-induced phenotype, 
immunoregulation 
(69-72) 
I-Ek Vγ2Vδ5 
(clone) 
Alloreactivity (70) 
Herpes Simplex 
Virus glycoprotein I 
Vγ2Vδ8 
(clone) 
Herpes Simplex Virus infection (73) 
Cardiolipin, 
apolipoprotein H 
Vγ1 (clones) Recognition of cardiolipin+ bacteria 
and apoptotic eukaryotic cells 
(74) 
Phycoerythrin (PE) 0.02-0.4% of 
γδ T cells 
Microbial recognition (65) 
Insulin peptide (B:9-
23) 
Vγ1 (clones) αβ T cells and B cells that recognise 
the same peptide mediate diabetes in 
non-obese diabetes (NOD) mice 
(75;76) 
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The γδ TCR repertoire suggests a role for γδ T cells in “lymphocyte stress surveillance” 
because they recognise molecules that are induced on “stressed” cells as a result of infection 
or transformation. This is similar to the role of patrolling macrophages and DCs whereas 
αβ T cells, on the other hand, recognise antigens processed and presented by myeloid 
antigen presenting cells and therefore fit in to the immune response at a later time. Another 
important group of molecules recognised by γδ TCRs seem to be autoantigens such as a 
myelin glycosphingolipid, histidyl-tRNA synthetase and a processed insulin peptide which 
imply a role for γδ T cells in the onset of autoimmunity. 
Antigens recognised by γδ TCRs include host molecules that are induced on activated, 
stressed or cancerous cells such as T10 and T22 in the mouse (69-72), and MICA, MICB 
and ULBP4 in the human (59-61). Another MHC related molecule that is recognised by γδ 
TCRs, specifically Vδ1+ clones, is CD1c (62), which can present self and microbial lipid-
based antigen and is upregulated during inflammation-induced monocyte differentiation to 
DCs. Therefore, the recognition of CD1c and other MHC related molecules may be part 
of a common mechanism of stress surveillance by γδ T cells which seems to be primarily 
a function of Vδ1+ cells in humans. 
Human Vδ1+ cells expand and exert anti-viral responses during CMV infection (77-82) 
and the TCR of a γδ T cell clone from a cytomegalovirus (CMV)-infected patient was found 
to directly bind endothelial protein C receptor (EPCR), which allowed the γδ T cells to 
recognise both endothelial cells targeted by cytomegalovirus and epithelial tumours (64). 
Therefore, these γδ TCRs recognise stressed human cells by engaging stress-regulated self-
antigens. 
In healthy individuals, Vδ1+ cells, which are more prevalent in tissues than in peripheral 
blood, have been found to react to CD1d loaded with sulfatide (63), a glycosphingolipid 
present in myelin. Vδ1+ cells have also been found to recognise cardiolipin complexed 
with apolipoprotein H (74). Cardiolipin is a lipid present in many bacteria and in the inner 
mitochondria membrane. During early apoptosis it translocates to the eukaryotic cell 
membrane where it is bound by serum apolipoprotein H. This complex was found to be 
recognised by Vγ1+ clones. It could allow γδ T cells to recognise apoptotic eukaryotic cells 
and perhaps promote their clearing by releasing proinflammatory cytokines to recruit 
macrophages. Additionally, murine γδ T cell clones also respond to a processed insulin 
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peptide without the need for an MHC molecule (75). Recently, the microbial antigen 
phycoerythrin (PE) was found to be recognised by a large percentage of naïve human and 
mouse γδ T cells (65). A γδ T cell clone has also been identified that responds to a herpes 
simplex virus glycoprotein (73). 
However, the antigens that have been better studied so far belong to a group collectively 
called “phosphoantigens”. These phosphorylated small molecular weight moieties activate 
the majority of γδ T cells present in human and primate blood. Surprisingly, given their 
ubiquity in human blood, these γδ T cells are not found outside the primate world. They 
are characterised by a TCR composed of Vγ9 and Vδ2 chains. Vγ9Vδ2 T cells, in most 
healthy individuals, make up nearly 90% of all γδ T cells in peripheral blood (83-85). The 
other main subset in humans pairs with Vδ1 chains and is the predominant γδ T cell subset 
found at mucosal sites. This striking lack of diversity is thought to arise from a large 
expansion of the Vγ9Vδ2 subset early in life (86). 
The Vγ9Vδ2 pairing recognises the microbial metabolite (E)-4-hydroxy-3-methyl-but-2-
enyl pyrophosphate (HMB-PP) which is present in many pathogenic, opportunistic and 
commensal microbes (87). In this way the Vγ9Vδ2 pairing functions almost as a pattern-
recognition receptor and allows for a rapid immune response without the need for prior 
selection and expansion that is necessary to generate αβ T cell responses. In fact, substantial 
expansion of human Vγ9Vδ2+ cells is found in the acute phase of a large number of 
bacterial (88-101) and protozoan (95;102-109) infections, including some with the highest 
burden of disease worldwide such as malaria and tuberculosis, and food-borne pathogens 
common in the developing world such as Listeria monocytogenes and Toxoplasma gondii. The 
Vγ9Vδ2 pairing also responds to an endogenously produced phosphoantigen called 
isopentenyl pyrophosphate (IPP). IPP is an intermediate generated in the mevalonate 
pathway of isoprenoid synthesis and is a precursor in cholesterol synthesis and cholesterol 
derivatives (steroid hormones, vitamin D, bile salts, and lipoproteins). Both stressed and 
transformed cells frequently have a dysregulated mevalonate pathway and accumulate high 
amounts of IPP which marks them for recognition (and killing) by Vγ9Vδ2 T cells (110) 
which has implications for both cancer and autoimmunity. Vγ9Vδ2 T cells quickly home 
to perturbed human skin such as inflamed psoriatic lesions (111). Their clinical importance 
can also be highlighted by the fact that low numbers of circulating Vγ9Vδ2 T cells are a 
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negative biomarker in prognostic scoring for ovarian cancer (112). Interestingly, the 
endogenous levels of IPP can be manipulated using clinically relevant drugs. 
Aminobisphosphonates such as zoledronate, which are used to treat osteoporosis and 
some types of bone cancer increase the intracellular accumulation of IPP by inhibiting the 
IPP-processing enzyme farnesyl pyrophosphatase (FPP) synthase. As a consequence, 
treatment of tumour cells with aminobisphosphonates increases their susceptibility to γδ 
T cell-mediated killing, which has generated a lot of interest in cell-based immunotherapies. 
Clinical trials have used either ex vivo expanded autologous Vγ9Vδ2 T cells or the 
administration of aminobisphosphonate drugs to patients alone. Partial tumour remissions 
have been reported for the in vivo drug administration trials. (113). A separate class of 
compounds - alkylamines - also activate Vγ9Vδ2 T cells (114) through the same 
mechanism. These compounds are found in dietary plants such as tea (114;115), apples 
(116) and wine (117). However, their potency in activating Vγ9Vδ2 T cells is 500-fold lower 
than that of aminobisphosphonates, owing to a much weaker inhibition of FPP synthase 
(118). Finally, in addition to activating Vγ9Vδ2 T cells in a TCR-dependent manner (119), 
phosphoantigens also require cell-cell contact (120) and fail to bind soluble Vγ9Vδ2 TCR 
(121). These features are all suggestive of an antigen presenting molecule but its identity 
has remained elusive until recently. A report by Vavassori et al, recently published in Nature 
Immunology, identifies butyrophilin 3A1 (CD277) as the long sought after cell surface-bound 
antigen-presenting molecule for phosphoantigens to Vγ9Vδ2 T cells (122). This molecule 
is ubiquitously expressed which explains why Vγ9Vδ2 T cells themselves were found to 
present phosphoantigens to other Vγ9Vδ2 T cells (120). 
Another interesting aspect of γδ T cells that sets them apart from conventional αβ T cells 
is their striking lack of TCR diversity. Although the potential for diversity generated 
through V(D)J recombination is similarly high in both γδ T cells and αβ T cells, the γδ TCR 
antigen specificities and the frequency of these antigen specific cells described so far 
suggest that the γδ TCR antigen repertoire could be considerably smaller than that of the 
αβ TCR. The actual αβ T cell antigen-specific repertoire has been estimated at 
approximately 106 different antigens. In contrast, the γδ TCR repertoire was estimated by 
Chien et al based on the list of γδ TCR ligands described so far to be in the range of 103-
104 different antigens, similar to the B cell antigen-specific repertoire (57). 
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This striking lack of TCR diversity is particularly visible in human blood were oligoclonal 
populations expressing the Vγ9Vδ2 TCR make up the overall majority of γδ T cells. This 
surprising dominance is not present at birth but develops during childhood and then 
persists throughout adulthood. In fact, by 1 year of age less than 5% of Vγ9Vδ2 T cells are 
naïve, in contrast to the majority of Vδ1+cells (123). One possible explanation for this 
could be extensive clonal expansion as a consequence of the continuous exposure to 
environmental microbial ligands during childhood (86) since the Vγ9Vδ2 TCR responds 
to common bacterial antigens. 
In conclusion, γδ TCRs recognise a variety of antigens, some of which are exclusive to γδ 
T cells and therefore widen the scope of immune responsiveness provided by αβ TCRs. 
They suggest a role for γδ T cells in the monitoring of tissues to look for stress-induced 
molecules that could signal transformation or infection. Importantly, the scope of γδ TCR 
recognition also implies a role for γδ T cells in the pathology of autoimmunity. 
2.4.2 The functions of γδ T cells in the immune response 
γδ T cells have multiple roles in the immune response. They respond rapidly to danger 
signals and are among the earliest producers of inflammatory cytokines in many infection 
settings. They are also potent cytotoxic effectors against infected or tumour cells and 
murine models deficient in γδ T cells seem more prone to developing some types of cancer. 
Additionally, γδ T cells located in tissues such as the gut and the skin maintain immune 
homeostasis through the promotion of tolerance, wound healing and the removal of 
infected or transformed cells. They are particularly important during pregnancy in 
promoting tolerance to the developing fetus and protecting it from CMV. They are also 
particularly prevalent and relevant in early life where the αβ T cell compartment is typically 
impaired. Evidence from early life and other states where αβ T cell functions are impaired 
such as in children with immunodeficiencies and αβ T cell (-/-) murine models suggests 
that γδ T cells can compensate for αβ T cells particularly in B cell help promoting antibody 
production. However, the specificity of the antibodies produced is often against self and 
in these cases γδ T cells may cause autoimmunity. At last, evidence from γδ T cell deficient 
mice suggests that γδ T cells may have a role in terminating the immune response as these 
mice commonly have exacerbated αβ T cell activity resulting in tissue damage. 
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In this section, current knowledge of the main roles of γδ T cells in the immune response 
will be discussed. At the end, potential roles for γδ T cells in phagocytosis and antigen 
presentation to αβ T cells will be introduced in more detail. 
2.4.2.1 Early producers of inflammatory cytokines 
In terms of functional properties, γδ T cells have well established roles as cytotoxic 
effectors against infected and tumour cells, as well as inflammatory cytokine producing 
cells, particularly IFN-γ and TNF-α. Their capacity to recognise antigens that are displayed 
after infection or other forms of stress and to respond rapidly to these without the need 
for extensive clonal expansion, equips γδ T cells for the early stages of the immune 
response. 
γδ T cells produce inflammatory cytokines that are involved in protective immunity against 
viruses and intracellular pathogens (IFN-γ and TNF-α), extracellular bacteria and fungi (IL-
17A) and extracellular parasites (IL-4, IL-5 and IL-13). In infections, γδ T cells respond 
earlier than αβ T cells. For instance, they are the major initial producers of IFN-γ after 
Listeria monocytogenes infection and of IL-4 after Nippostrongylus brasiliensis infection and 
appear days before the αβ T cell response develops (124). γδ T cells are also early non-
redundant producers of IFN-γ in vivo after Mycobacterium tuberculosis (Mtb) infection in mice 
which enhances IL-12 production by dendritic cells in the lung and stimulates DCs to 
prime Mtb-specific CD8+ αβ T cells more efficiently in the lung (125). In addition, γδ T 
cells contribute to pathogen clearance directly, by producing bacteriostatic or lytic 
molecules, such as granulysin and defensins (126;127). They are also non-redundant players 
in controlling vaccinia virus infection, as γδ T cell-deficient mice infected with this virus 
show increased mortality and higher virus titres compared to WT mice (128). 
In the mouse, γδ T cells are the primary source of the neutrophil-attracting cytokine IL-
17A both helping to clear bacterial infections and exacerbating autoimmune pathologies. 
This rapid IL-17A production has been demonstrated in various mouse models of bacterial 
infection (129-131) and autoimmunity (132-135) including rheumatoid arthritis (132), 
psoriasis (136), type 1 diabetes (137) and progressive renal failure (138). In lung allergy 
models, IL-17A production by γδ T cells has conflictingly been attributed to the resolution 
of airway inflammation (139;140). In humans however, IL-17-producing γδ T cells are not 
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readily detected typically making up less than 1% of the Vγ9Vδ2+ cells in the peripheral 
blood of healthy donors (141;142). However, they make up the majority of γδ T cells found 
in the blood and cerebrospinal fluid of children suffering from bacterial meningitis and 
they can be generated in in vitro cultures from naïve Vγ9Vδ2+ cells with the polarising 
cytokines IL-1-β, TGF-β, IL-6, and IL-23 (143). IL-17-producing γδ T cells have also been 
found in HIV patients where they belong to the Vδ1 subset (144). 
2.4.2.2 Cell-mediated cytotoxicity 
γδ T cells use cell-mediated cytotoxicity to kill infected, activated or transformed cells. 
Although NK cells are notorious MHC-unrestricted cytotoxic killers there is evidence to 
suggest a non-redundant role for γδ T cells in certain settings. For instance, γδ T cell-
deficient mice develop cutaneous tumours faster than WT mice challenged with the 
mutagen methylcholanthrene or skin tumour cell lines (145;146). This protection in WT 
mice is mediated by both the early production of IFN-γ (146) and direct lysis of 
transformed cells (145) by γδ T cells. 
Cytotoxic pathways used by γδ T cells are the same as those used by CD8 T cells and NK 
cells, namely the engagement of death-inducing receptors, such as Fas and other members 
of the TNF-family, and the release of cytotoxic molecules such as perforin and granzymes 
(126;147). Cytotoxicity through the granule exocytosis pathway can be induced by the 
recognition of tumour or infected cells through the γδ TCR or through NK receptors. In 
particular, NKG2D is expressed on the vast majority of γδ T cells and can trigger 
cytotoxicity either alone or as a co-stimulatory signal following Vγ9Vδ2 TCR recognition 
(148). The importance of NKG2D is supported by the various strategies used by viruses 
and tumours to evade it (149;150). Cytotoxicity in γδ T cells seems to be mainly confined 
to the CD16+ and/or CD56+ subset (151;152). These cells are thought to develop quickly 
from the differentiation of more common CD16- CD56- central memory γδ T cells (153). 
Finally, the induction of cytotoxicity in γδ T cells can also be mediated by CD16-IgG 
opsonised target interactions much in the same way as for NK cells (154).  
Antibody-dependent cytotoxicity (ADCC) by γδ T cells has been demonstrated by different 
groups. Tokuyama et al showed that γδ T cells expanded from healthy donors and subjects 
with malignancy were ADCC effectors with trastuzumab coated HER2-overexpressing 
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breast cancer cells, and with rituximab coated CD20+ lymphoma cell lines (Daudi, Raji 
and Ramos) (152). A different group used expanded γδ T cells from healthy donors and 
follicular lymphoma patients to demonstrate ADCC with a novel anti-CD20 monoclonal 
antibody called GA101 and primary follicular lymphoma cells (155). Another group 
reported that expanded γδ T cells from healthy donors or HIV patients were efficient 
ADCC effectors against a head and neck cancer cell line – 012SCC – in the presence of 
cetuximab, an anti-epidermal growth factor receptor monoclonal antibody (156). The same 
authors gave an oral presentation at the 16th International Symposium on HIV and 
Emerging Infectious Diseases about as yet unpublished findings that γδ T cells from elite 
HIV controllers have retained ADCC potential as compared to normal HIV patients and 
that expanded γδ T cells from these elite HIV controllers are able to kill Env-decorated 
targets in the presence of opsonising antibody (157). In addition, cross-linking of CD16 on 
γδ T cells can also result in TNF-α (158) or IFN-γ (155;159;160) production. Interestingly, 
in vivo CMV-expanded γδ T cells from transplantation recipients with CMV infections 
expressed CD16 but their anti-CMV action was not mediated by ADCC and instead was 
due to IFN-γ production after cross-linking of CD16 by IgG-opsonised virions (160). The 
authors hypothesize the lack of ADCC effector function could be due to the low levels of 
anti-CMV IgGs found in the patients. In addition, it should be mentioned that the previous 
ADCC studies focused on phosphoantigen-expanded Vγ9Vδ2 T cells whereas CMV-
expanded γδ T cells are predominantly of the Vδ1 subtype (80). IFN-γ production by γδ T 
cells was additionally enhanced by IL-12 and IFN-α and inhibited CMV multiplication. 
2.4.2.3 Tissue homeostasis 
Tissue-associated γδ T cells are commonly Vδ1+ with Vδ3+ and Vδ5+ being additional 
minor populations (161) and their main role is maintaining immune homeostasis in the 
local microenvironment (162). They have an important role in wound healing through the 
production of epithelial growth factors, remove distressed or transformed epithelial cells 
and dampen excessive inflammation (163-166). In the intestinal tract they play a non-
redundant role in maintaining tolerance to food antigens as well as the intestinal flora 
(164;167). An increased number of γδ TCR+ IEL is also observed in humans in celiac 
disease (168-172) and inflammatory bowel syndrome (173) and there is evidence that they 
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dampen inflammation by suppressing αβ TCR+ IEL function (167). Vδ1+ cells are also 
particularly important in pregnancy and early life. 
During pregnancy a heightened immune tolerance and protection from infection need to 
be balanced to both prevent rejection of the semiallogeneic embryo and successfully 
support its growth for 9 months. γδ T cells have been observed at the maternal/fetal 
interface throughout pregnancy in humans, mice (174) and sheep(175). In humans, Vδ1+ 
cells are recruited to the maternal/fetal interface (176) and are the most frequent type of 
γδ T cells found in the blood in healthy pregnancy. Strikingly, in women that have suffered 
from recurrent abortions (177) or are deemed at risk due to clinical symptoms (178) the 
Vγ9Vδ2 subset remains the most frequent in the blood during pregnancy. These 
observations strongly support a role for Vδ1+ cells in maintaining immunotolerance to the 
fetus which is further supported by findings that these cells produce IL-10 and TGF-β in 
the human decidua (179). 
2.4.2.4 Interactions with other immune cells 
γδ T cells modulate the behaviour of other cells through the release of soluble intermediates 
or cell-cell contact. For instance, in vitro studies show that Vγ9Vδ2 T cells can induce 
maturation of DCs through a cell-cell contact dependent production of IFN-γ and TNF-α 
(180;181), and reciprocally, immature DCs induce activation of Vγ9Vδ2 T cells (182). 
γδ T cells may also play a part in the termination of the immune response. For instance, in 
murine influenza virus infection, γδ T cells emerge late after pathogen numbers have 
declined (183). These late γδ T cell responses could contribute to the resolution of 
inflammation since γδ T cell-deficient mice develop larger and longer lasting inflammatory 
lesions when challenged with intracellular bacteria (184). In a different murine model, mice 
lacking γδ IELs displayed an exaggerated immunopathology to Eimeria vermiformis gut 
infection, as a result of failure to control αβ T cell responses (185). Therefore, γδ T cells 
could act late in the immune response to dampen αβ T cell responses. 
γδ T cells may also have an important role in B cell function which is apparent from studies 
with αβ T cell deficient mice and immunocompromised individuals.  
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During the humoral immune response, antigen is transported into secondary lymphoid 
organs. Here, T cells expressing CXCR5 respond to the chemokine B-cell-attracting 
chemokine 1 (BCA-1/CXCL13) by migrating to the B cell region and interact resulting in 
germinal centre (GC) formation. It is at these structures that the processes of somatic 
hypermutation, class switch recombination and affinity maturation of activated B cells 
occur which result in the generation of memory B cells and antibody secreting plasma cells 
(186). In the absence of T cell help, antigen priming leads to B cell apoptosis (187). 
Follicular helper T cells (TFH) are defined by their follicular location and by the high 
expression of specific markers: CXCR5, the inhibitory receptor PD-1 and the 
costimulatory molecule ICOS, which interact with specific ligands on B cells, and the 
cytokine IL-21 which acts on B cells (188). In secondary lymphoid organs, such as the 
tonsils, CD4+ αβ T cells compose the majority of CXCR5+ T cells. However, small subsets 
of CD8+ αβ T cells (189) and invariant NK T cells (190-192) can also provide B cell help 
albeit to a lesser extent. Interestingly, αβ TCR-deficient mice develop normal germinal 
centres and class-switched antibodies which suggests that a different cell type such as γδ T 
cells could compensate for the lack of these cells (193-195). However, the antibodies 
produced in these mice are mostly against self-antigens, strongly supporting a role for γδ 
T cells in autoimmunity.  
In healthy humans, CXCR5+ γδ T cells can be found in small numbers in circulation and 
are able to provide B cell help in vitro (196). In addition, Vγ9Vδ2 T cells can be driven to a 
TFH phenotype after phosphoantigen stimulation in the presence of IL-21 (197-199). These 
in vitro derived γδ TFH produce large amounts of BCA-1, which in addition to its 
chemotactic role for CXCR5+ cells also promotes the upregulation of molecules that 
promote follicular dendritic cell maturation (200). In vivo, lessons from 
immunocompromised individuals strongly support the ability of γδ T cells to provide B 
cell help and suggest a link to autoimmunity. This may be particularly relevant in diseases 
characterised by a reduced αβ T cell compartment such as AIDS which are often associated 
with autoimmunity. 
No γδ T cell (-/-) individual has been identified so far which would suggest that the 
phenotype is either embryonic lethal or so mild as to not cause significant complications. 
However, some patients have been described with severely reduced numbers of αβ T cells 
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but normal numbers of γδ T cells. Together, their phenotypes suggest an important role 
for γδ T cells in modulating the behaviour of other immune cells. 9 cases so far have been 
observed with a hypomorphic mutation in the recombinase activating gene 1 (RAG1) that 
leads to a partial RAG-1 deficiency and severe combined immunodeficiency (SCID) 
(www.orpha.net). Two RAF-1-deficient SCID reports were published in the same issue of 
the Journal of Clinical Investigation. One of them presented a patient with severely reduced 
αβ T cell numbers but normal γδ T cell numbers with a diversified oligoclonal repertoire 
and predominance of Vγ4Vδ3+ cells (201). Several of the γδ T cell clones displayed 
reactivity against CMV. Specific antibodies against vaccines, infections, and also 
autoantibodies could be found despite minimal B cell numbers. The other publication 
reported RAG1-deficient SCID in 4 patients from separate families. The phenotype 
consisted of oligoclonal expansion of CMV-reactive γδ T cells combined with αβ T cell 
lymphopenia and autoimmunity. The patients all displayed autoimmune cytopenias 
(anemia in 3 patients and neutropenia in 1) and had either anti-red blood cell or anti-
polymorphonuclear autoantibodies (202). These phenotypes support a role for γδ T cells 
in providing B cell help to stimulate antibody production and in promoting autoimmunity. 
In support of this role in autoimmunity, elevated levels of γδ T cells are observed in 
children with autoimmune thrombocytopenic purpura, a disorder characterised by 
immune-mediated antiplatelet destruction. (203). The levels of γδ T cells in these children 
correlate with the degree of thrombocytopenia and the γδ T cells are mainly of the Vγ9Vδ2 
TCR subset. Interestingly, in vitro studies with γδ T cells from healthy adults also report 
that a subset of γδ T cells present in human blood can promote B cell function and these 
cells expresses the Vγ9Vδ2 TCR (196). However, the RAG1-deficient patients did not have 
an overrepresentation of the Vγ9Vδ2 subset in the blood which is typical of their young 
age and will be enhanced by CMV-induced expansion of other subsets. 
Other genetic disorders can cause a similar phenotype to RAG1 deficiency. Partial CD3δ 
and TCRα defects have been described that result in combined immunodeficiency with 
severely reduced numbers of αβ T cells, but normal numbers of γδ T cells, B cells and NK 
cells (204;205). Although these patients suffered from immune dysregulation and 
autoimmunity they did not succumb to infection and remained relatively healthy for some 
years on antibiotic prophylaxis. They were able to produce class-switched antibodies and 
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to mount antibody responses to both vaccination and auto-antigens. Therefore, evidence 
from these immunodeficiency patients again suggests that γδ T cells can play an important 
role in promoting autoimmunity by promoting the production of autoantibodies. 
2.4.2.5 Importance in early life 
γδ T cells may be particularly important in early life. In all embryonic animal models where 
it was investigated, γδ T cells are the first type of T cell to be detected in the thymus and 
the first to leave and populate the periphery (206-209). They can be detected in the murine 
thymus by embryonic day 14 (210) and by week 8 in humans (211). Their ontogeny is 
similar to αβ T cells. Bone marrow precursor cells migrate to the thymus where they 
rearrange their TCR-γ, TCR-δ and TCR-β loci in an attempt to generate a productive γδ 
TCR or pre-TCR (TCR-β paired with an invariant pre-TCR-α). This competition, 
combined with the signal strength of TCR signalling, directs the cell towards a γδ T cell or 
αβ T cell fate (212). As αβ T cells emerge from the thymus, the relative proportion of γδ T 
cells in circulation start to decrease. Interestingly, unlike αβ T cells, which are nearly 
exclusively dependent on the thymus for their development and maturation, some γδ T 
cells seem to be generated in extrathymic sites. In particular, Vδ1+ cells are present in 
athymic mice (213) and it is interesting that a skewed Vδ1+/Vδ2+ ratio is found in the 
blood of HIV-1 patients since this infection is characterised by a loss of thymic function 
(214). 
The prevalence of γδ T cells in early life suggests that they may contribute preferentially to 
neonatal protection, when αβ T cell responses are functionally impaired and DCs are 
immature. Evidence for the role of γδ T cells in neonatal protection is further discussed 
with particular emphasis on CMV.  
Human cytomegalovirus (CMV) is the most common cause of congenital infection, 
affecting around 0.64% of live births (215). CMV can translocate the placental barrier and 
infect the developing fetus and it can also infect the baby through maternal breast milk. 
Infection is usually asymptomatic in adults but may cause serious sequelae in the neonate 
including hearing loss, vision loss and mental retardation. In the adult immune system there 
is compelling evidence for CMV-specific CD4 T cells as critical controllers of CMV 
infection (216;217). However, the immune system of the neonate is qualitatively different 
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from the adult. A dramatic expansion of fetal Vδ1+ cells is seen in human cytomegalovirus 
(CMV) infection in utero (79) and these cells differentiate into strong IFN-γ producing 
effectors. It is therefore possible that γδ T cells in utero functionally replace the CD4 T cell 
Th1 responses that are characteristically low in pregnancy and newborns (218;219). Fetal 
γδ T cells in congenital CMV had upregulated cytotoxic mediators including granzymes, 
perforin, granulysin, FasL and TRAIL which equipped them for cell-mediated cytotoxicity. 
In addition, clones from CMV-infected newborns efficiently killed CMV-infected cells and 
limited CMV replication in vitro. Therefore, there is strong evidence that γδ T cells mediate 
protection in the developing fetus in congenital CMV. 
Additional evidence of the competence of γδ T cells to protect the host in early life are 
found in a study comparing γδ T cells and αβ T cells from the blood of neonates (220). 
The authors found neonate γδ T cells showed stronger in vitro cytokine responses upon 
stimulation particularly for IFN-γ which is typically impaired in neonate αβ T cells and 
mediates protection against intracellular parasites, bacteria and certain viruses. Therefore, 
γδ T cells are well equipped to contribute to immunoprotection in the neonate, possibly 
compensating for the selective immaturity of the αβ T cell compartment during this critical 
period. In addition, in two mouse models of parasite gut infection, γδ T cells were found 
to be required for the protection of young but not adult mice (221;222). γδ T cells may 
therefore contribute disproportionally to immunity in young animals. 
2.4.3 Phagocytosis by γδ T cells 
Lymphocytes are not usually considered phagocytic cells. Our general understanding of 
immunology is that the phagocytic response is both an early and a late event in the immune 
response and that the main players are neutrophils, macrophages and dendritic cells. 
Although all cells in the body can sample their extracellular environment to some extent, 
these professional phagocytes share among them tools that allow them to recognise and 
engulf pathogens and cell debris highly efficiently. They share among them machinery that 
allows them to destroy engulfed pathogens and then to alert other immune cells of their 
presence. In 2009, a group presented evidence of professional phagocytosis performed by 
γδ T cells from the blood of healthy donors (223). The authors used freshly isolated γδ T 
cells to demonstrate phagocytosis of opsonised particles and also antigen presentation to 
αβ T cells after co-stimulation with phosphoantigens and B-LCL help. Wu et al showed 
43 
 
detailed microscopic evidence of internalised Escherichia coli and 1 µm beads by freshly 
isolated human peripheral blood γδ T cells. Why have other groups not reported similar 
observations? Phagocytosis in γδ T cells may not be an obvious feature because of three 
facts: first, the lack of abundant phagocytic receptors on γδ T cells, second, constraints of 
cell size, and third, competition with professional phagocytes. These particular constraints 
will be examined followed by a discussion of the possible relevance of phagocytosis by γδ 
T cells in the immune response. 
Phagocytosis is a receptor-mediated process and T cells do not have an abundance of 
phagocytic receptors. However, a proportion of γδ T cells in the blood express the cell-
surface receptor CD16, although with considerable variability among different donors and 
different reports (158-160;223-226). Although this receptor is also found on NK cells, 
where it mediates antibody-dependent cytotoxicity, it is a phagocytic receptor in 
macrophages. It can also induce phagocytosis if transduced into COS-1 cells that were 
previously not phagocytic (227). Importantly, CD16 binds IgG-coated particles and 
therefore cells expressing only this phagocytic receptor can only exhibit phagocytosis 
towards IgG-opsonised targets. Accordingly, blocking of CD16 substantially decreased 
antigen presentation from phagocytosed particles in Wu et al’s original work (223). 
Secondly, there are constraints of cell size. The restrictions on phagocytosis may be 
mechanical as phagocytes need to have a sufficient volume of cytoplasm to accommodate 
the phagocytosed particle. Steady-state lymphocytes typically have a very high nucleus to 
cytoplasm ratio unlike professional phagocytes. For example, B cells are not phagocytic 
(228) but malignant B cells transform into cells with a large macrophage-like morphology 
that are capable of ingesting large particles by phagocytosis (229-231). Nonetheless, bovine 
activated γδ T cells acquire a different morphology to resting T cells, with an enlarged 
cytoplasm and occasional membrane protrusions similar to dendritic cells (232). Moser’s 
group described a similar morphology in in vitro activated human Vγ9Vδ2 T cells (233). In 
addition, Wu et al detailed the presence of γδ T cells with a dendritic-like morphology in 
small numbers in the blood of healthy donors without any deliberate in vitro activation or 
active infection (223). Therefore, although most γδ T cells have the morphology of small 
lymphocytes, with a small round body and a very small cytoplasm to nucleus ratio, small 
numbers of larger dendritic-like γδ T cells may be present among circulating cells in 
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peripheral blood (223). In addition, isolated γδ T cells quickly acquire a similar morphology 
upon activation (232;233). 
Finally, phagocytosis by γδ T cells may not be evident due to competition by professional 
phagocytes. In phagocytosis experiments containing mixed populations of leukocytes, 
professional phagocytes such as neutrophils and monocytes may take up microbes much 
more efficiently than γδ T cells, as they display a variety of phagocytic receptors on their 
surface. In addition, they are present in significantly higher numbers in the blood whereas 
γδ T cells are a minor population in human blood in the absence of infection. The vast 
majority of leukocytes in the blood are neutrophils (around 70%) and about 10% of 
PBMCs are monocytes, whereas only around 1-5% of T cells generally express a γδ TCR. 
For all these reasons conventional professional phagocytes have a significant competitive 
advantage over γδ T cells in their opportunity to phagocytose and can make use of a variety 
of different receptors to recognise their target. Therefore, they will be preferentially seen 
to phagocytose in mixed populations of cells. 
However, it is interesting to think of the possibility of phagocytosis in γδ T cells from an 
evolutionary point of view. Curiously, the 3D structure of γδ TCRs is more similar to 
immunoglobulins (Ig) than to αβ TCRs. The CDR3 loops in the γ and δ chains, the key 
components for antigen recognition, very closely resemble the CDR3 regions of Ig light 
chains and heavy chains, as opposed to those of the α and β chains in αβ TCRs (234-236). 
This was taken to suggest that the recognition of antigen by γδ T cells may be more similar 
to the binding of antibody to antigen than the MHC/peptide complex recognised by αβ T 
cells, but in addition, it may also suggest a separate evolution of γδ and αβ TCRs. 
Phylogenetic studies of the constant region of T cell receptors suggest that TCR γ and δ 
sequences are more ancient than TCR α and β sequences, implying that the ancestral 
immune cell was more like a modern γδ T cell than a modern αβ T cell (237). According 
to this phylogenetic analysis, the γδ T cell-like ancestor then gave rise to αβ T cells and B 
cells. In this way, γδ T cells are thought to predate αβ T cells and B cells in evolution. Since 
phagocytosis arose long before adaptive immunity, the initial γδ T cell-like ancestor may 
have shared innate and adaptive immunity properties. Phagocytosis may therefore be a 
feature retained to some extent by modern γδ T cells. Another argument in line with the 
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possibility of phagocytic cells in the modern γδ T cell population is that not all developing 
γδ T cells depend on the same molecular switch for lineage commitment. This raises the 
possibility that phenotypically distinct γδ T cell lineages may co-exist (238) and that 
therefore a distinct γδ TCR+ lineage may have retained the ability for phagocytosis. 
The best supporting evidence for an evolutionary explanation for γδ T cell phagocytosis 
would be the presence of phagocytic γδ T cells in evolutionarily more primitive animals. 
Although no such studies have been reported for γδ T cells, a report in Nature Immunology 
highlighted the surprising high phagocytic ability of B cells from the rainbow trout and 
catfish (239). The uptake of bacteria was followed by phagolysosome formation and 
intracellular killing. These animals are teleost fish, which were the first animal species to 
evolve adaptive immunity (240). This report therefore shows evidence of phagocytic ability 
in one of the earliest evolved adaptive immune cells. Notably, phagocytic IgM+ 
lymphocytes represented 62% of all peripheral blood phagocytes and so were not a minor 
population which suggests that phagocytosis co-existed in the first evolved adaptive 
immune cells.  
The earlier report of professional phagocytosis in γδ T cells (223) leaves important 
questions that the work leading to this thesis has tried to address. For instance: 
 Is phagocytosis a feature of a particular type of γδ TCR+ cell? 
 What proportion of γδ T cells phagocytose? 
 How does this compare to other cells of the immune system? 
 Do γδ T cells produce microbicidal products after bacterial engulfment? 
The answers to these questions would help frame what role γδ T cell phagocytosis could 
play in the immune response. For instance, γδ T cell phagocytosis could play a role locally 
at infection sites after B cell humoral responses. γδ T cells, being one the earliest players in 
the immune response, would initially exert cytotoxicity and produce inflammatory 
cytokines while neutrophils and tissue macrophages phagocytosed. Later, after the 
generation of specific antibodies, γδ T cells at the infection site might help clear the 
infection more quickly through the recognition and uptake of antibody coated pathogens 
or pathogen fragments. In this case, experimental phagocytosis should find phagocytosis 
46 
 
restricted to the Fc receptor expressing subset of γδ T cells. Since some γδ T cells have 
been shown to produce bacteriostatic substances (126;127) they may also be able to destroy 
the engulfed pathogen, therefore controlling the spread of infection. Additionally, γδ T 
cells could play a role in modulating the antigen-specific αβ T cell response enhancing it 
locally by presenting engulfed pathogen antigens and inducing the expansion of previously 
selected antigen specific αβ T cells. Presentation after phagocytosis in γδ T cells could 
perhaps even dampen the immune response and help terminate it if phagocytosis and 
antigen processing and presentation happens temporally late and antigen is presented in 
the absence of co-stimulation. A cell type simultaneously capable of cytotoxicity, 
phagocytosis and of stimulating antigen-specific αβ T cell responses could prove a useful 
tool in cancer immunotherapy and Vγ9Vδ2 T cells can be readily expanded ex vivo for 
reinfusion (241). 
2.4.4 Antigen presentation by γδ T cells to αβ T cells 
At the time of the beginning of this thesis, there were two isolated reports of professional 
antigen presentation in human γδ T cells (223;233). In addition, there were reports of MHC 
class II antigen presentation in bovine (232), porcine (242), and murine (243) γδ T cells. 
The field has since grown with additional insights on the ability of human γδ T cells to 
cross-present microbial, virus and tumour antigen to CD8+ αβ T cells (244-246). In 
addition, the mechanism for cross-presentation seems to involve the cytosolic pathway 
(247) and activation signals required for professional antigen presentation function have 
been identified (233;246). Therefore, there is hope that these insights can be applied to 
improve γδ T cell-based tumour immunotherapy approaches (248). 
The first report of professional antigen presentation was in Science in 2005 by Brandes et 
al (233). Activated Vγ9Vδ2 T cells rapidly acquired features of professional antigen 
presenting cells including the expression of the class II antigen presentation molecule 
HLA-DR and the co-stimulatory molecules CD80/86 and CD40, as well as the lymph node 
homing molecule CCR7. In addition, the morphology of the γδ T cells changed and they 
developed a markedly activated appearance often with long membrane projections. Phase 
contrast images of γδ T cell cultures showed cells with the appearance of being highly 
motile.  These characteristics are very reminiscent of the prototypical antigen presenting 
cell – the mature dendritic cell. Immature dendritic cells are specialised to internalise and 
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process antigens, and keep MHC class II molecules is endocytic compartments (249). Upon 
stimulation, they mature into powerful inducers of T cell immunity. These express high 
levels of surface MHC class II (249) and have the appearance of large, nonadherent, stellate 
and motile cells (250). Mature DCs express an abundance of T cell adhesive and co-
stimulatory molecules. The authors showed that upon activation with a TCR agonist and 
IL-2, in the presence of B-LCL feeder cells, Vγ9Vδ2 T cells rapidly altered their 
morphology and phenotype towards that of mature dendritic cells. Functionally, activated 
Vγ9Vδ2 T cells could induce primary αβ T cell responses to the same extent as LPS-
matured DCs. They could also process and present the soluble protein antigens tetanus 
toxoid (TT) and the complex protein mixture Mycobacterium tuberculosis-purified protein 
derivative (PPD). Activation of TT- and PPD-specific CD4 T cells was blocked by 
chloroquine and with a blocking anti-HLA-DR antibody, demonstrating requirements for 
both active processing and presentation via HLA-DR for αβ T cell activation. It should be 
noted that simply stimulating freshly isolated γδ T cells with phosphoantigen and IL-2 does 
not equip them with antigen presentation properties, as was shown recently by a study 
using transcriptome analysis that did not find APC markers on phosphoantigen-activated 
γδ T cells (251). This points to an interesting and as yet undefined role for B-LCL help in 
the induction of an APC phenotype in these cells. 
Wu et al added to these findings by describing a mechanism by which γδ T cells could 
acquire antigen for presentation (223). The authors showed that human γδ T cells were 
capable of taking up Escherichia coli and influenza M1 protein coated 1 µm beads when these 
were specifically opsonised with IgG antibodies. The authors therefore infer that human 
γδ T cells are capable of Fc-mediated phagocytosis. Accordingly, presentation of M1 
antigen was disrupted in the presence of an anti-CD16 blocking antibody, in addition to 
being sensitive to chloroquine and HLA-DR blocking. 
Subsequent studies have focused on cross-presentation, or the ability of these cells to 
degrade exogenous protein and load it on MHC class I (244;245;247;248). Cross-
presentation by γδ T cells could have important implications as γδ T cells are highly 
cytotoxic and a functional link between cytotoxicity and antigen presentation could amplify 
the immune response to cancer or infection. In addition, as mentioned previously, cross-
presentation is particularly important for naïve T cell activation, in the case where a 
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pathogen does not infect APCs or even when a tumour arises in a non-APC cell type (49). 
The anti-tumour cytotoxicity of γδ T cells is well established in the literature. Therefore, if 
antigen is acquired locally from tumour cell debris then γδ T cells could be potent inducers 
of anti-tumour adaptive immunity. Since γδ T cells can be readily expanded ex vivo to large 
numbers (252-254), they could potentially be used in novel approaches to tumour 
immunotherapy. 
Activated Vγ9Vδ2 T cells outperformed dendritic cells in cross-presentation of exogenous 
particulate antigen, which was shown to occur via macropinocytosis (247). 
Macropinocytosis is used by immature dendritic cells as part of their normal function to 
sample the local environment and to induce tolerance to self-antigens. A substantial 
portion of internalised particulate antigen in activated Vγ9Vδ2 T cells was exported to the 
cytosol and degraded by the proteasome. γδ T cells were also capable of cross-presenting 
cellular debris and displayed delayed endosomal acidification, which is thought to 
contribute to the preservation of antigens in DCs. This data suggests the cytosolic pathway 
as a mechanism for cross-presentation of particulate antigens in γδ T cells. 
Our own group investigated the regulation of professional antigen presentation in cross-
presenting human γδ T cells (246). In addition to the previously described requirements 
for TCR ligation, IL-2 and B-LCL help, the authors showed a potent, reversible second 
signal via CD16 ligation to opsonised tumour cells. The presence of opsonised tumour 
cells was sufficient to induce a level of cross-presentation similar to mature DCs. The same 
effect could not be seen in the presence of antibody, tumour cells alone, or non-binding 
antibody and tumour cells. This signalling was termed “licensing”, drawing parallels from 
the licensing for potent antigen presentation in DCs through CD40-CD40L ligation by 
CD40L-expressing CD4 T cells (255-257). The effect was reversible as separating γδ T cells 
and opsonised tumour cells resulted in a loss of the ability of these cells to cross-present, 
accompanied by a loss of surface co-stimulatory molecules. This study raises the possibility 
that we could improve on current γδ T cell immunotherapy trials (113) by combining the 
capacity of γδ T cells for ADCC (152;155-157) with a concomitant stimulation of cross-
presentation of tumour associated antigens (244-246) and improve anti-cancer immunity. 
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In the work described in this thesis the MHC class II antigen presentation experiments 
established by Wu et al were replicated (223). In addition, γδ T cells were compared with 
other lymphocytes in the blood to further establish whether professional antigen 
presentation function is a unique feature of Vγ9Vδ2 T cells activated in this way. Also, 
because CD16 was demonstrated in the original work by Wu et al to be important in 
antigen uptake for presentation, and this same receptor is known to mediate ADCC in γδ 
T cells (152;155-157), I investigated whether ADCC, as opposed to direct cytotoxicity, 
could be used as an efficient mechanism of antigen uptake for class II presentation in γδ T 
cells. Of note, relevant studies had been published with NK cells, where incubation of NK 
cells with NK-sensitive but not NK-insensitive tumour cell targets led to the transient 
activation of MHC class II antigen presentation function by the NK cells (258;259). A 
similar study with γδ T cells had been conducted ex vivo by following an in vivo bovine foot-
and-mouth disease virus infection (260). In this study, γδ T cells were shown to exert high 
cytotoxicity and concomitantly acquired MHC class II antigen presentation function 
transiently during the acute phase of infection. These studies suggest that cytotoxic 
effectors can be activated through NK cell receptors to acquire antigen presentation 
function and aid anti-virus and anti-tumour immunity. 
The experiments described in this thesis aim to help clarify the extent of phagocytosis in 
human γδ T cells and the settings in which it could play a role (ADCC, after humoral 
responses). In addition, I have tried to include other relevant lymphocytes (αβ T cells and 
NK cells) in the experimental design, to investigate whether phagocytosis and subsequent 
antigen presentation is unique to γδ T cells or whether other lymphocyte subsets share a 
similar plasticity. 
In summary, in addition to phagocytosis, this thesis studies MHC class II presentation of 
exogenous antigen by γδ T cells. The main aims of the antigen presentation experiments 
described in this thesis are: 
 To replicate the original work by Wu et al (223) describing class II presentation of 
influenza M1 antigen by γδ T cells but additionally include αβ T cells and NK cells 
in the same experiments in order to elucidate whether class II presentation is a 
unique feature of these cells among similar lymphocyte subsets 
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 To investigate whether antigen can be acquired by γδ T cells from infected target 
cells coated with antibody and whether this antigen is later presented by the γδ T 
cell via MHC class II 
The answers to these questions may help clarify what role phagocytosis and class II 
antigen presentation by γδ T cells could play in the immune response. 
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3 Materials and Methods 
3.1 Materials 
3.1.1 Cell isolation 
The following materials were used to isolate PBMC or PMN fractions from whole blood 
and to isolate different cell types from PBMCs. 
Table 4 – Reagents used for the isolation of cells from whole blood 
Reagent Supplier Cat no. 
Ficoll-Paque GE Healthcare 17-1440-03 
Dextran Sigma D4876 
anti-γδ TCR microbead kit Miltenyi Biotec 130-050-701 
anti-PE microbeads Miltenyi Biotec 130-048-801 
anti-CD56 microbeads Miltenyi Biotec 130-050-401 
NK cell isolation kit Miltenyi Biotec 130-092-657 
anti-CD14 microbeads Miltenyi Biotec 130-050-201 
LS columns Miltenyi Biotec 130-042-401 
MS columns Miltenyi Biotec 130-042-201 
 
3.1.2 Bacteria and bacterial growth media 
Escherichia coli strain DH5α containing the plasmid pAKgfp1 were acquired from Addgene 
(plasmid #14076). The bacteria were grown in LB broth (20g Luria broth base (Sigma 
#L3022) + 1L ddH2O + autoclaving) supplemented with 100 µg/ml ampicillin (Sigma 
#A9518) and 1mM IPTG (Sigma #I1284), or in bacterial plates made with LB agar (35g 
LB agar (Sigma #19344) + 1L ddH20 + autoclaving) supplemented with 100 µg/ml 
ampicillin. 
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3.1.3 Cell lines and cell culture media 
Primary cells and cell lines were grown in either complete RPMI media or complete 
DMEM media as described in the following table.  
Table 5 – Reagents used for the culture of mammalian cells 
Media Cells Description 
Complete RPMI Human T cells, 
NK cells, 
monocytes, 
neutrophils, 
Daudi, K562, B-
LCL  
RPMI (Gibco #61870) 
10% (v/v) heat-inactivated FCS (Sigma #F7524) 
1% (v/v) penicillin/streptomycin (Gibco 
#15140) 
Hybridoma 
media 
A1C5 hybridoma DMEM (Gibco #61965) 
10% (v/v) heat-inactivated FCS 
1% (v/v) penicillin/streptomycin 
1% (v/v) non-essential amino acids (Gibco 
#11140-035) 
1% (v/v) pyruvate (Gibco #11360-039) 
50 µM β-mercaptoethanol (Gibco #31350-010)  
Freezing media Various 90% FCS 10% DMSO 
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3.1.4 Buffers and solutions 
All dilutions volume/volume (v/v) for liquids and weight/volume (w/v) for solids unless 
otherwise stated. 
Table 6 – Buffers and solutions used throughout this study 
Buffers/Solutions Recipe/Manufacturer 
Dulbecco’s phosphate buffered saline 
(DPBS) 
Gibco #14190-094 
Phosphate buffered saline (PBS) 10x PBS tablets were dissolved in ddH20 
PBS-T PBS + 0.05% Tween 20 
0.1% Triton PBS + 0.1% Triton X 
4% paraformaldehyde diluted from 16% stock from Alfa Aesar 
#43368 
ELISA blocking buffer PBS-T + 5% BSA 
ELISA stop solution 1M Sulfuric acid 
ELISA substrate Becton Dickinson #555214 
FACS buffer DPBS + 0.5% FCS + 2mM EDTA 
MACS buffer DPBS + 0.5% FCS + 2mM EDTA, 0.2 µm 
sterile filtered 
RIPA buffer 25mM Tris-HCl pH 7.6, 150mM NaCl, 1% 
NP-40, 1% sodium deoxycholate, 0.1% 
SDS 
Laemmli’s buffer (2x) 0.5M Tris-HCl pH 6.8, 10% glycerol, 2% 
SDS and bromophenol blue, 100mM DTT 
Western blocking buffer PBS-T + 5% BSA 
Western ECL reagent SuperSignal West Pico Chemiluminescent 
Substrate, Thermo Scientific #34080  
Western running buffer diluted from 20x NuPAGE MOPS SDS 
running buffer (Invitrogen #NP0001) 
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Western transfer buffer diluted from 20x NuPAGE transfer buffer 
(Invitrogen #NP0006) 
Talon buffer 50 mM Na-phosphate, pH 8.0 + 300 mM 
NaCl + 0.01% Tween 20 
Fix & lyse buffer for comparative 
phagocytosis assay 
diluted from 10x stock from Glycotope 
Biotechnology’s PHAGOTEST kit 
Fix & lyse buffer for general flow 
cytometry 
eBioscience #00-5333-54 
saline 0.9% NaCl 
Fast green methanol Medion Diagnostics #F04660/90 
Eosin Y in PBS Medion Diagnostics #F04662/90 
Thiazine dye Medion Diagnostics #F04663/90 
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3.1.5 Antibodies 
A list of all the antibodies used in this study is provided in Table 6, together with their use 
and working dilution. For flow cytometry, antibody dilutions are commonly described as 
µl of antibody added per test. A test is defined as the amount of antibody used to stain a 
cell sample in a final volume of 100 µl. Cell number can range from 105 to 108 cells/test. 
Table 7 – Antibodies used throughout this study 
Antibodies Supplier Cat no. Dilution 
Magnetic cell isolation    
αβ TCR-PE eBioscience 12-9986 20 µl/test 
Flow Cytometry    
γδ TCR-FITC eBioscience 11-9959 5 µl/test 
γδ TCR-PE eBioscience 12-9959 5 µl/test 
γδ TCR-APC Becton Dickinson 555718 5 µl/test 
CD3-eFluor450 eBioscience 48-0038 5 µl/test 
CD3-APC Biolegend 300412 5 µl/test 
αβ TCR-APC Biolegend 306717 5 µl/test 
CD56-APC Becton Dickinson 555518 20 µl/test 
CD14-APC Becton Dickinson 561708 20 µl/test 
CD27-PE eBioscience 12-0271 0.7 µl/test 
CD45RA-APC eBioscience 17-0458 5 µl/test 
CD16-eFluor450 eBioscience 48-0168 5 µl/test 
CD16-APC eBioscience 17-0168 5 µl/test 
CD16-PerCP-Cy5.5 Biolegend 302027 5 µl/test 
HLA-DR-APC eBioscience 17-9956 5 µl/test 
CD80-PE eBioscience 12-0809 5 µl/test 
CD86-PE Becton Dickinson 555665 20µl/test 
mouse IgG1-eFluor450 isotype 
control 
eBioscience 48-4714 5 µl/test 
mouse IgG1-FITC isotype control Becton Dickinson 555748 20 µl/test 
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mouse IgG1-PE isotype control eBioscience 12-4714 5 µl/test 
mouse IgG1-APC isotype control eBioscience 17-4714 5 µl/test 
mouse IgG1-PerCP-Cy5.5 isotype 
control 
eBioscience 45-4714 5 µl/test 
biotin anti-human IgG Vector 
Laboratories 
BA-3000 1:200 
fluorescein streptavidin Vector 
Laboratories 
SA-1200 1:100 
Alexa Fluor 405-conjugated anti-
rabbit IgG 
Invitrogen A31556 1:1000 
Fluorescence Confocal Microscopy    
anti-γδ TCR mouse IgG1 Becton Dickinson 555716 0.1 µg/ml 
Cy5-conjugated anti-mouse IgG Invitrogen M35011 0.25 
µg/ml 
Western blot    
anti-γδ TCR mouse IgG1 Beckman Coulter PN 
IM1349 
1 µg/ml 
anti-GAPDH rabbit polyclonal IgG Santa Cruz Biotech FL-335 1 µg/ml 
HRP-conjugated anti-mouse IgG Invitrogen 626520 1:1000 
HRP-conjugated anti-rabbit IgG Dako P 0448 1:2000 
Functional cell assays     
mab2G12 NIBSC EVA 3064 10 µg/ml 
Rituximab Roche - 10 µg/ml 
human IgG1 isotype control Calbiochem 400120 10 µg/ml 
anti-HLA-DR blocking antibody Becton Dickinson 347360 10 µg/ml 
mouse IgG2α isotype control Becton Dickinson 554126 10 µg/ml 
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3.1.6 Kits and miscellaneous 
Table 8 – Other reagents 
Item Supplier Cat no. 
Mouse IL-2 ELISA R&D DY402 
Dynabeads Invitrogen 10103D 
SeeBlue Plus2 Prestained 
Standard 
Invitrogen P/N100006636 
Fluorescent cell 
labelling 
  
CFSE Invitrogen C34554 
DiI Invitrogen V-22886 
PKH26 Sigma MINI26 
Live/Dead Fixable Far 
Red Dead Cell Stain 
Invitrogen L10120 
Alexa Fluor 555-labelled 
phalloidin 
Invitrogen A34055 
Chemicals   
Isopentenyl 
pyrophosphate (IPP) 
Sigma I0503 
Recombinant human IL-2 PeproTech 200-02 
Cytochalasin D Sigma C8273 
Dimethyl amiloride 
(DMA) 
Sigma A 4562 
Chloroquine Sigma C6628 
Nitroblue tetrazolium Sigma 84010 
Gentamicin Sigma G1272 
Protease inhibitor Sigma P8340 
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3.2 Methods 
3.2.1 Tissue culture 
3.2.1.1 Blood collection 
Blood was collected from healthy volunteers by venopuncture using a blood collection set 
(Greiner bio-one #450153) into conical tubes containing 3 IU/ml of heparin (AppliChem 
#A3004,0250). Blood was kept at room temperature (RT) until processing and was 
routinely used within 2h of collection. 
3.2.1.2 PBMC isolation 
PBMCs were isolated from the peripheral blood of healthy volunteers using a standard 
Ficoll-Paque separation. Briefly, collected blood was diluted 1:2 in Dulbecco’s PBS (DPBS) 
and layered over 15 ml of Ficoll-Paque in conical tubes. The blood was spun at 350 g for 
20 min at RT, with the centrifuge brake off. The white buffy layer was aspirated and washed 
once in DPBS at 300 g for 5 min before magnetic separation. 
3.2.1.3 Isolation of polymorphonucleated cells from whole blood 
PMN fractions were isolated from whole blood with a dextran sedimentation step followed 
by a Ficoll-Paque separation. 2 ml of 10% dextran (in saline) and 2 ml of 1x saline were 
added to 10 ml of freshly collected blood in a conical tube. The tube was mixed by inversion 
and allowed to settle for 30-45 min at RT. The top plasma layer was removed. The 
remainder was layered over an equal volume of Ficoll-Paque and spun at 400 g for 10 min 
at RT. The supernatant was aspirated. The pellet was quickly ressuspended in 10 ml of 
ddH2O to lyse the red blood cells and immediately mixed with 10 ml of 2x saline to restore 
isotonicity. The cells were spun for 180 g for 7 min to pellet the cells and ressuspended in 
warm complete RPMI. 
3.2.1.4 Magnetic separation 
γδ T cells were routinely isolated from PBMCs using a positive magnetic isolation kit. In a 
routine isolation 50 ml of blood were used to separate PBMCs. PBMC pellets were 
ressuspended in 200 µl of ice-cold MACS buffer and 50 µl of the anti-γδ TCR hapten 
antibody included in the kit were added. The cells were incubated on ice for 10 min. After 
that time, 150 µl of ice-cold MACS buffer were added, followed by 100 µl of anti-hapten 
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FITC magnetic beads included in the kit. The cells were incubated on ice for 15 min. The 
cells suspension was topped up to 10 ml with ice-cold MACS buffer and spun at 300 g for 
5 min at 4°C. The supernatant was carefully aspirated and the remaining pellet was 
ressuspended in 500 µl of ice-cold MACS buffer and loaded onto a freshly prepared LS 
column. 3 washes were made with 3 ml of ice-cold MACS buffer. The cells were eluted by 
removing the column from the magnet and plunging 5 ml of ice-cold MACS buffer 
through. The cells were pelleted at 300 g for 5 min at 4°C. The pellet was ressuspended 
again with 500 µl of buffer and loaded onto a freshly prepared MS column. The column 
was rinsed three times in buffer and the cells were eluted in 1 ml of buffer. 
To check for purity, the cells suspension was mixed by pipetting and 95 µl were taken and 
incubated with 5 µl of CD3-eFluor450 antibody. The cells were stained in the fridge for 20 
min in polystyrene FACS tubes. The cells were washed once at 300 g for 5 min at 4°C. The 
supernatant was removed and the cells were ressuspended in 100 µl. The cells were placed 
on ice and taken to the flow cytometry facility to check for purity. Purity was assessed as 
the % of CD3+ γδ TCR+ cells and was routinely 96-98%. 
Monocytes were isolated in a similar way by positive magnetic isolation with a different kit. 
NK cells were generally isolated using a negative magnetic isolation kit to deplete non-NK 
cell types (Miltenyi Biotec #130-092-657). A positive isolation kit was used when 
mentioned in results chapter 5 (Miltenyi Biotec #130-050-401). αβ T cells were isolated 
with a PE-conjugated pan-αβ TCR antibody followed by anti-PE magnetic beads and one 
MS column. 
3.2.1.5 Activation of γδ T cells 
When indicated, γδ T cells were activated according to Moser’s original protocol for γδ T 
APC maturation (233). Briefly, 1x106 allogeneic non-HLA-DRB1*0101 B-LCL cells were 
irradiated at 80 Gy and seeded into 0.5 ml of complete RPMI, supplemented with IPP (50 
µM) and IL-2 (100 IU/ml). The feeder cells were rested in the incubator during the γδ T 
cell magnetic isolation. Freshly isolated γδ T cells isolated from 50 ml of peripheral blood 
were ressuspended in prewarmed media and added to the well. The cells were co-cultured 
for 18h at 37°C 5%CO2. 
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3.2.1.6 Hybridoma cell culture 
The hybridoma cell line A1C5 was a kind gift from Dr David Canaday from Case Western 
Reserve University, Cleveland, US (261). The hybridoma cells were kept at a concentration 
of 0.2-1x106 cells/ml. Cell concentration is crucial with this cell line so hybridoma cells 
were thawed 3-4 days before an antigen presentation assay, and the cell concentration was 
adjusted daily with fresh media to 0.2-0.5x106 cells/ml. 
3.2.2 Flow cytometry 
3.2.2.1 Basic assessment of surface markers 
PBMCs, magnetically isolated cells or whole blood were incubated with fluorochrome-
conjugated antibodies or the matched isotype control at the appropriate volumes as listed 
in Table 6. All antibodies were stained for 20 min at 4°C in polystyrene FACS tubes. The 
cells were washed once with approximately 2 ml of FACS buffer at 300 g for 5 min at 4°C 
and ressuspended and analysed within the hour in a BD LSRII flow cytometer. 
Alternatively, cells were fixed with 1 ml of lyse& fix reagent for 20 min at RT, which also 
lyses red blood cells in whole blood samples. Samples were analysed on a BD LSRII flow 
cytometer. Generally, 10 000 events of the cell type of interest were acquired. The results 
were analysed with FlowJo (version 7.6.5.).  
3.2.2.2 Dual-labelling phagocytosis assay 
γδ T cells were freshly isolated by magnetic selection as previously described. The cell 
viability was confirmed by trypan blue exclusion and the cell number was counted with a 
haemocytometer chamber. 200 000 cells were seeded in polystyrene FACS tubes in 200 µl 
of complete RPMI. Opsonised fluorescein-labelled E. coli were prepared as previously 
described. γδ T cells and bacteria were incubated on separate tubes for 10 min on ice. 20 
µl of opsonised bacterial suspension was added to the well at an approximate ratio of 100 
bacteria: 1 γδ T cell. The tubes were incubated at 37°C for 45 min in a waterbath with 
gentle swirling halfway through. A squirt bottle containing DPBS was chilled in the fridge 
at 4°C, and the centrifuge was pre-cooled. After 45 min, all tubes were placed on ice. The 
samples were washed in approximately 2 ml of cold DPBS and spun at 300g for 5 min at 
4°C. The supernatant was removed with an aspirator and the remaining pellet was 
ressuspended in the remaining liquid with a P200 pipette. A 1:1000 dilution of Alexa Fluor 
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405-conjugated anti-rabbit IgG antibody was added. The antibody should bind the rabbit 
IgG portion in the opsonised non-engulfed bacteria. The samples were incubated for 20 
min at 4°C. The samples were washed once in approximately 2 ml of cold DPBS and spun 
at 300g for 5 min at 4°C. The supernatant was removed with an aspirator and the remaining 
pellet was ressuspended in the remaining liquid with a P200 pipette. The samples were 
placed on ice and taken to the Flow Cytometry facility where they were analysed within the 
hour in a BD LSRII flow cytometer. The results were analysed with FlowJo (version 7.6.5.). 
3.2.2.3 Comparative phagocytosis assay in whole blood 
GFP-expressing E. coli were grown in 3 ml of sterile LB media supplemented with 
ampicillin and IPTG at 37°C overnight. The bacteria were washed once in DPBS and then 
opsonised with 25 µl of opsonising reagent for 30 min at 37°C. A blood sample was 
collected from a healthy donor during this incubation period. The heparinised blood 
sample was split into separate polystyrene FACS tubes. After the bacterial opsonisation, 
the bacteria were washed in 1 ml DPBS and spun at 14 000 g for 2 min at RT. The bacteria 
were ressuspended thoroughly in 20 µl and then in a further 180 µl. FACS tubes and 
bacteria were pre-chilled separately for 10 min on ice. The bacteria were mixed by 
vortexing. 20 µl of the bacteria suspension were added per tube while the tubes were on 
ice. Bacteria and leukocytes were mixed by briefly vortexing. The tubes were placed in a 
37°C waterbath except for one which was kept on ice as a control. The tubes were swirled 
halfway through the incubation time. A squirt bottle with DPBS was chilled at 4°C. The 
centrifuge was pre-chilled. After 30 min in the waterbath, all tubes were transferred to ice. 
Approximately 2 ml of cold DPBS were added per tube and they were spun at 300 g for 5 
min at 4°C. The tubes were placed again on ice. The supernatant was removed down to 
the red pellet with a bench aspirator and a P200 pipette leaving the leukocytes in a residual 
volume of approximately 200 µl. Antibodies were added as described in Table 8 and the 
cells were mixed by gentle vortexing. 
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Table 9 – Antibody staining for comparative flow cytometry phagocytosis assay 
Tube Label Antibodies 
1 γδ T cells 10 µl γδ TCR-APC 
10 µl CD3-eFluor450 
2 αβ T cells 10 µl αβ TCR-APC 
10 µl CD3-eFluor450 
3 NK cells 40 µl CD56-APC 
10 µl CD3-eFluor450 
4 monocytes 40 µl CD14-APC 
5 ice control - 
 
The cells were stained for 20 min at 4°C. The tubes were placed again on ice and washed 
with ice-cold DPBS at 300 g for 5 min at 4°C. The supernatant was removed, the cells were 
ressuspended with gentle vortexing and 2 ml of lyse & fix reagent were added per tube (10x 
stock from Glycotope Biotechnology’s PHAGOTEST kit, diluted 2 ml in 19 ml of 
ddH2O). The cells were mixed with a P1000 pipette. The cells were incubated for 20 min 
at RT in the dark. The tubes were spun at 300 g for 5 min at 4°C. The cells were placed on 
ice and analysed by flow cytometry in a BD LSRII flow cytometer within an hour. The 
results were analysed with FlowJo (version 7.6.5.). 
3.2.2.4 Cell-mediated cytotoxicity assay 
Effector cells were seeded at the mentioned E:T ratios with a constant target cell number 
of 10 000 targets. When an E:T ratio is not mentioned, an E:T=10 with 100 000 effector 
cells was used per well. Effector cells were seeded in 100 µl in complete RPMI in a U 
bottom 96-well plate. The plate was kept in the incubator at 37°C 5%CO2 while the targets 
were prepared. 3 ml of target cell culture containing between 1.5-3x106 cells were 
transferred to a 15 ml conical tube. Targets cells used were either K562, H9 or HH cells, 
as mentioned. The cells were spun at 300 g for 2 min at RT. The cells were washed 1x in 
10 ml of DPBS to remove all traces of protein in the supernatant which is crucial for 
PKH26 staining. The cells were ressuspended in 200 µl of diluent C (part of PKH26 kit). 
In a separate tube, 2 µl of PKH26 were mixed with 400 µl of diluent C to make a 2x stock. 
200 µl of this 2x stock was immediately mixed with the cell suspension and incubated for 
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3 min at RT in the dark. The staining was quenched with 400 µl of FCS, prewarmed to RT, 
an incubated for 1 min. The cells were spun at 300 g for 2 min at RT. The supernatant was 
aspirated and the cells were washed once in 10 ml of DPBS. The cells were ressuspended 
in 1 ml of complete RPMI and counted. For direct cytotoxicity assays, the target cells were 
ressuspended at 1x105 cells/ml and 100 µl were added per well. For antibody-dependent 
cytotoxicity assays, target cells were incubated with 10 µg/ml of mab2G12 or human IgG1 
for 30 min at RT in microcentrifuge tubes. After 30 min, the antibody coated cells were 
added to the wells with no washing step. The plate was spun at 200 g for 1 min at RT and 
carefully placed in the incubator. The cells were co-cultured for 4h at 37°C 5%CO2. After 
4h the plate was spun at 300 g for 5 min. A sample of PKH26-labelled targets was snap 
frozen in the absence of a cryoprotectant to use as a control to set the “dead targets” gate. 
Untouched PKH26-labelled targets cells were also used as a control to visualise “live 
targets”. The supernatant was aspirated and the cells were ressuspended in 150 µl of DPBS. 
The plate was spun again and the cells were ressuspended in 50 µl of DPBS. A 1:500 
dilution of Live/Dead Fixable Far Red dye was prepared and 50 µl were added per well. 
The wells were mixed with pipetting and the cells were stained for 30 min at RT, protected 
from light. The plate was spun again. The supernatant was decanted. The cells were washed 
once in DPBS and ressuspended in 2% paraformaldehyde. The cells were fixed for 15 min 
at RT and placed in the fridge o.n. before being analysed by flow cytometry in a BD LSRII 
flow cytometer. The results were analysed with FlowJo (version 7.6.5.). 
3.2.3 Fluorescence confocal microscopy 
Cells were analysed by fluorescence confocal microscopy in polylysine coated slides 
(Vector Laboratories #H-4000). The cells were added to 1 cm3 wells drawn with a wax pen 
(Thermo Scientific #J2800AMNZ). The cells were incubated in a volume of approximately 
150 µl of complete RPMI at 37°C 5%CO2 for different times depending on the assay. 
Afterwards, the slides were taken out of the incubator, rinsed in PBS and fixed in 100 
µl/well of 4% paraformaldehyde for 15 min at RT. The slides were rinsed 3x in PBS and 
permeabilised in 100 µl/well of 0.1% Triton (10 ml PBS + 10 µl Triton) for 7 min at RT. 
The slides were rinsed 3x in PBS and blocked in 100 µl/well of 3% BSA (0.3g BSA + 10 
ml PBS) for 30 min at RT. The slides were rinsed 3x in PBS and stained with 1° antibodies 
as mentioned in the assays in 100 µl of PBS for 30 min at RT. The slides were rinsed 3x in 
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PBS and stained with 2° antibodies for 30 min at RT. The slides were rinsed 3x in PBS and 
1x in ddH20 and mounted. Mounting media ProLong Gold antifade reagent with DAPI 
(Invitrogen #P36935) was allowed to warm to RT for 10 min before use. Excess moisture 
from the slides was removed by tapping the side of the slide on a clean paper towel. One 
drop of mounting media per well was added and the well was sealed with a coverglass 
(Heathrow Scientific #HEA159879H). The samples were cured overnight (o.n.) at RT in 
the dark. The next day, the edge of the coverslips was sealed with nail polish and the sample 
was stored at 4°C until examination with a fluorescence confocal microscope (Zeiss LSM 
710). 
3.2.3.1 Phagocytosis assays 
Opsonised fluorescein-labelled E. coli were prepared as the following description. 
Fluorescein-labelled killed Escherichia coli (K-12 strain) and opsonising reagent were 
acquired from Invitrogen (#E-2861 and #E-2870, respectively). The opsonising reagent is 
derived from purified rabbit polyclonal IgG antibodies specific for E. coli. and both 
products are supplied as lyophilised powders. The E. coli vial contains 10 mg at 
approximately 3x108 E. coli per mg of solid. This vial was reconstituted at 20 mg/ml in 
DPBS. The tubes were capped and the particles were gently swirled into suspension, 
followed by vigorous vortexing. Reconstituted suspensions were stored at 4°C in the dark 
until use. The opsonising reagent is sufficient to opsonise 10 mg of the matching 
lyophilised E. coli. The opsonising reagent was reconstituted in 500 µl of sterile ddH20 and 
stored at -20°C in single-use aliquots. E. coli suspensions were freshly opsonised before 
each experiment in the following way. Equal volumes of opsonising reagent and the 20 
mg/ml suspension of E. coli were mixed in a sterile 1.5 ml microcentrifuge tube and 
incubated for 30 min at 37°C in a waterbath, in the dark. The opsonised bacteria were 
washed 1x with 1 ml of DPBS at 14 000 g for 2 min. The pellet was ressuspended in DPBS 
and added to the γδ T cells. 
γδ T cells were freshly isolated by magnetic selection as previously described. The cell 
viability was confirmed by trypan blue exclusion and the cell number was counted with a 
haemocytometer chamber. 20 000 – 40 000 γδ T cells and opsonised fluorescein-labelled 
E. coli were seeded per well on polylysine slides. The slides were kept in the incubator at 
37°C 5%CO2 for 45 min. After that incubation period, the slides were fixed, permeabilised, 
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blocked, stained and mounted as mentioned earlier. The 1° antibody used was 1 µg/well 
of mouse IgG1 anti-γδ TCR antibody diluted in 100 µl of PBS. As a 2° antibody, 2.5 
µg/well of Cy5-conjugated anti-mouse IgG antibody were diluted in 100 µl of PBS. 
Together with the 2° antibody, F-actin was stained with 1:100 Alexa Fluor 555-labelled 
phalloidin. Pictures were taken using a Zeiss LSM710 fluorescence confocal microscope. 
To compare phagocytosis across different cell types, a slightly different phagocytosis assay 
was performed. γδ T cells, αβ T cells, NK cells and monocytes were isolated by magnetic 
isolation from PBMCs as previously described. For each experiment, 50 ml of blood were 
drawn from a healthy donor. PBMCs were isolated by Ficoll separation and ressuspended 
in 50 ml of DPBS. Of these, 7 ml were transferred to a separate tube for monocyte 
isolation, 7 ml for NK cell isolation and 2 ml for αβ T cell isolation. The remaining volume 
was used for γδ T cell isolation. After magnetic isolation, the samples were ressuspended 
in 100 µl of MACS buffer and fluorochrome-conjugated monoclonal antibodies were 
added as described in Table 9. The samples were stained for 20 min at 4°C and washed 
once in MACS buffer before cell sorting on a MoFlo XDP flow cytometer. 
Table 10 – Antibody staining for FACS sorting of magnetically isolated fractions 
Sample Magnetic isolation staining Further staining for FACS sorting 
γδ T cells γδ TCR-FITC 5 µl CD3-APC 
αβ T cells αβ TCR-PE 5 µl CD3-APC 
NK cells - 5 µl CD3-APC  
20 µl CD56-PE 
monocytes - 20 µl CD14-APC 
 
The FACS sorted cells were seeded onto 1 cm3 wells drawn in polylysine slides. Opsonised 
fluorescein-labelled E. coli or opsonised GFP-expressing E. coli were prepared as described 
previously, and added to the slides at a ratio of 100 bacteria to 1 leukocyte. The slides were 
incubated at 37°C 5%CO2 for 45 min. The slides were then fixed, permeabilised, blocked, 
stained and mounted as previously mentioned. No antibodies were used so that the pictures 
could remain anonymous throughout scoring. However, in order to visualise the cell body, 
F-actin was stained with 1:100 Alexa Fluor 555-labelled phalloidin. 100 pictures were taken 
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per well. The pictures were anonymised and randomised using the purpose build 
“RenameRandom” software before being analysed. Each picture was scored using the “cell 
counter” plugin in the microscopy analysis software Image J. 
3.2.3.2 Acquisition of target cell antigen 
Magnetically isolated γδ T cells were stained with CFSE. For CFSE labelling, the cells were 
ressuspended at 1x106/ml in prewarmed PBS/0.1% BSA. One vial of CFSE powder was 
reconstituted in 18 µl of DMSO to make a CFSE stock. 2 µl of CFSE stock were added 
per ml of cell suspension. The cells were incubated for 10 min at 37°C. CFSE staining was 
quenched by the addition of 5 volumes of ice cold complete RPMI and incubation on ice 
for 5 min. The cells were spun at 300 g for 5 min at RT and ressuspended in 10 ml of 
complete RPMI. The cells were washed 3x in media and rested in the incubator at 37°C 
5%CO2 while the Daudi cells were stained. Daudi cells were stained with the lipophilic 
orange-red fluorescent dye Vybrant DiI. Daudi cells were ressuspended at 1x106 cells/ml 
in prewarmed serum-free RPMI. 5 µl of DiI were added per ml of cell suspension. The 
cells and dye were mixed gently by pipetting and incubated for 5 min at 37°C. The cells 
were spun at 300 g for 5 min at RT and ressuspended in warm complete RPMI. The cells 
were washed 3x in complete RPMI. Afterwards, the cells were pelleted and incubated in a 
1.5 ml microcentrifuge tube with 10 µg/ml of Rituximab. The cells and antibody were 
incubated for 15 min at RT. γδ T cells and Daudi cells were mixed and seeded onto 
polylysine slides. The cells were co-cultured for 1h at 37°C 5%CO2. When indicated, the 
γδ T cells and Daudi cells were pre-incubated with 250 µM DMA or 5 µM Cytochalasin D, 
or both. The slides were mounted with a hard-set mounting media (Vector Labs #H-1400) 
as the mounting media usually used is not compatible with DiI.   
3.2.4 Microbiology 
3.2.4.1 GFP- E. coli culture 
GFP-expressing E. coli were grown fresh before each experiment in 3 ml of LB media 
supplemented with ampicillin and IPTG at 37°C overnight. 
3.2.4.2 Construction of a GFP-E. coli growth curve 
GFP-expressing E. coli were inoculated from a colony in a plate in 3 ml of LB media 
supplemented with ampicillin and IPTG at 37°C. A sample of 150 µl of the culture was 
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taken every hour for 8h. The sample was mixed by vortexing and 100 µl were diluted with 
900 µl of sterile DPBS (= -1 dilution). The sample was diluted a further 5 times in the same 
way and 100 µl of the -6 dilution were seeded in duplicate ampicillin plates. The optical 
density at 600 nm (OD 600) was measured in a spectrophotometer. For the first and second 
hours, OD 600 was measured with the -1 dilution. For the following hours the -6 dilution 
was used. In this way, photometric measurements were taken in the linear range (0.1 and 
0.5 OD 600). Ampicillin plates were incubated at 37°C overnight. The next day, colonies 
were counted using a colony counter. The concentration of the bacterial cultures was 
calculated from the number of colonies on the plate according to the following equation: 
𝐶𝐹𝑈
𝑚𝑙
=
𝑛𝑜. 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝑣𝑜𝑙𝑢𝑚𝑒 𝑝𝑙𝑎𝑡𝑒𝑑
 
3.2.4.3 Gentamicin protection assay 
For the gentamicin protection assay, leukocyte cones were used instead of freshly drawn 
blood as the number of γδ T cells needed exceeds what can reasonably be obtained from 
50 ml of blood. A leukocyte cone derives from a pint (568 ml) donation of blood. 
Leukocyte cones were obtained from the National Blood Service. PBMCs were isolated 
from leukocyte cones in the same way as previously described for fresh blood except 
instead of the blood being diluted 1:2 in DPBS, leukocyte cones containing around 8 ml of 
concentrated blood product were diluted to 50 ml in DPBS. After isolation of the PBMCs, 
the cell viability was confirmed by trypan blue exclusion and the cell number was counted 
with a haemocytometer chamber. Magnetic isolation of monocytes, γδ T cells and αβ T 
cells was performed in parallel from 100x106, 20x106 and 20x106 PBMCs from the same 
sample. The cells were ressuspended at 1x106/ml in complete RPMI without antibiotics 
and seeded at 100 000 cells/well in triplicate. Monocytes were seeded in flat-bottom 96-
well plates and T cells were seeded in U bottom 96-well plates to prevent cell loss during 
the washing steps. The number of GFP-expressing E. coli in the bacterial culture was 
estimated from the OD 600 to achieve an approximate ratio of 100 bacteria: 1 leukocyte. 
The bacteria were pelleted at 14 000 g for 2 min at RT in a microcentrifuge tube. The pellet 
was ressuspended with 25 µl of opsonising reagent and incubated for 30 min at 37°C in a 
waterbath. The bacteria were washed 1x in 1ml of DPBS. The bacteria were ressuspended 
in complete RPMI without antibiotics and 20 µl were added per well. A sample was seeded 
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onto ampicillin plates to confirm the bacteria: leukocyte ratio. The leukocytes and bacteria 
were incubated for 45 min at 37°C 5%CO2. The plates were spun at 300 g for 5 min at 4°C 
to pellet the cells. Supernatants were very carefully removed with a P200 pipette so as not 
to disturb the pellet. The pellets were ressuspended in 200 µl of cold DPBS/well and spun 
at 300 g for 5 min at 4°C. This step is crucial as it removes excess bacteria in suspension. 
Bacteria do not pellet well at 300 g unlike leukocytes which means the majority of them 
will be removed. The pellets were ressuspended in 150 µg/ml of gentamicin diluted in 
complete RPMI without antibiotics. The cells were incubated in gentamicin media for 1h 
at 37°C 5%CO2 to kill any remaining non-engulfed bacteria. After the incubation period, 
a sample of gentamicin supernatant was seeded onto ampicillin plates to confirm bacterial 
killing. Afterwards, the cells were washed 3x in 200 µl DPBS/well at 300g 5 min 4°C spins 
to remove any remaining traces of gentamicin. The supernatant was carefully removed 
from all the wells and the pellets were ressuspended in 100 µl of 0.1% Triton in DPBS/well 
(10 ml DPBS + 10 µl Triton). The lysis buffer was incubated for 15 min at RT to lyse 
eukaryotic cells and release phagocytosed bacteria. Lysis was confirmed by light 
microscopy. The entire contents of each well (100 µl) were diluted in 900 µl of sterile DPBS. 
The samples were thoroughly mixed by vortexing and 100 µl were seeded onto ampicillin 
agar plates. The plates were incubated o.n. at 37°C and colonies were counted the next day 
with a colony counter. 
3.2.5 Nitroblue tetrazolium (NBT) test 
A phagocytosis assay with opsonised GFP-expressing E. coli and whole blood was 
performed as described previously with CD3/γδ TCR staining with the only difference 
that the cells were not fixed in the last step and instead ressuspended in FACS buffer for 
sorting. The cells were FACS sorted on a MoFlo XDP. FACS sorted phagocytic and non-
phagocytic CD3+ γδ TCR+ cells and neutrophils were collected on flat-bottom 96-well 
plates. 1 µg/ml of NBT reagent was added to all wells and incubated at 37°C 5%CO2. After 
30 min of incubation, the wells were examined on a light microscope and pictures were 
taken with an attached digital camera. Cells with blue formazan precipitates were scored as 
NBT positive. 
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3.2.6 Diff-Quick staining 
A phagocytosis assay with opsonised GFP-expressing E. coli and whole blood was 
performed as described previously with CD3/γδ TCR staining. FACS sorted phagocytic 
and non-phagocytic CD3+ γδ TCR+ cells were collected on 1.5 ml microcentrifuge tubes. 
The cells were cytospun onto microscopy slides. The slides were fixed in fast green 
methanol for 1 min at RT, stained in Eosin Y in PBS for 1 min at RT and then stained in 
Thiazine dye in PBS for 1 min at RT. The slides were blotted for excess dye in between 
steps. The slides were blotted and allowed to air dry. Pictures were taken with a light 
microscope with a digital camera attached. The cells were scored according to morphology. 
To confirm the presence of eosinophils and neutrophils in a PMN fraction from whole 
blood I used the exact same staining procedure. Neutrophils can be identified by their 
purple multi-lobed nuclei and light cytoplasm and eosinophils stain orange-red for eosin 
granules and have bi-lobed nuclei. 
3.2.7 Western blot 
1x106 cells were pelleted in 1.5 ml microcentrifuge tubes at 300 g for 10 min at 4°C. Lysis 
buffer was prepared fresh by diluting 100 µl of protease inhibitor with 900 µl of RIPA 
buffer and kept on ice. After the cells were pelleted, the supernatant was removed and the 
cells were ressuspended in 40 µl of ice-cold lysis buffer. The cells were lysed for 30 min on 
ice and spun at 14 000 g for 10 min at 4°C. The supernatants were transferred to new 
microcentrifuge tubes and stored on ice. 2x Laemmli’s buffer was added to the 
supernatants, mixed and incubated at 85°C for 5 min. The samples and the SeeBlue Plus2 
Prestained Standard were separated by electrophoresis in a Novex 4-12% Bis-Tris gel in 1x 
MOPS buffer at 200V for 35 min. The separated proteins were wet-transferred onto a 
methanol-activated Immobilon-P PVDF membrane using the X-Cell II Blot Module and 
1x NuPAGE Transfer buffer containing 10% methanol at 30V for 1h. The membrane was 
blocked in PBS-T + 5% BSA for 1h at RT. Primary antibody staining was performed for 
1h with 1 µg/ml of anti-γδ TCR mouse IgG1 and 1 µg/ml of anti-GAPDH rabbit 
polyclonal IgG. The membrane was washed 3x with PBS-T and stained with HRP-
conjugated anti-mouse IgG (1:1000) and HRP-conjugated anti-rabbit IgG (1:2000) for 1h 
at RT. The membrane was washed three times in PBS-T and peroxidase activity was 
visualised with a Western ECL reagent and UviChemi chemiluminescence detection. 
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3.2.8 Chromium release assay 
A classic chromium release assay was used to validate the flow cytometry-based cytotoxicity 
assay developed for the CL3 lab. I tested PBMCs from the same donor in parallel with the 
two assays. The assays were performed in U bottom 96-well plates. The first 3 rows of 
columns A to G were seeded with 100 µl of complete RPMI. PBMCs were isolated and 
ressuspended at 2.5x106 cells/ml. 200 µl were seeded in the first column and serially diluted 
with 100 µl volumes and a P200 multipipette until column F so that the maximum E:T 
ratio had 250 000 PBMCs/well. Columns A to F correspond to different E:T ratios, 
whereas no effectors are added to column G. The plate was kept at 37°C 5%CO2 while the 
targets cells were prepared. K562 cells were counted and 2x106 K562 cells were pelleted at 
300 g for 5 min at RT. The cells were ressuspended in 180 µl of fresh warm complete 
RPMI. 20µl of chromium-51 (Perkin Elmer #NEZ030002MC) were added and the cells 
were incubated in a waterbath at 37°C for 1h. Chromium-labelled K562 cells were washed 
3x in DPBS and ressuspended in complete RPMI. The cells were counted and the 
concentration was adjusted to 5x104 cells/ml. 100 µl of targets were added to all the wells 
including an extra 3 rows of column I. The plate was spun at 200 g for 1 min at RT to 
promote effector and target cell contact. The plate was carefully removed from the 
centrifuge and 100 µl of 2% Triton were added to column I. The cells were carefully placed 
in the incubator at 37°C 5%CO2 for 4h. 50 µl of the supernatants were added to 150 µl of 
scintillation fluid (Perkin Elmer #1200-439) in a 96-well plate and radioactivity was read 
the next day. Specific lysis was calculated according to the following formula, where 
spontaneous lysis refers to wells with target cells in the absence of effectors and maximum 
lysis refers to target cells in the absence of effectors in the presence of 1% Triton: 
% 𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝐿𝑦𝑠𝑖𝑠 =
(𝑆𝑎𝑚𝑝𝑙𝑒 𝑐𝑝𝑚−𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝐿𝑦𝑠𝑖𝑠 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑝𝑚)
(𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝐿𝑦𝑠𝑖𝑠 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑝𝑚−𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝐿𝑦𝑠𝑖𝑠 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑝𝑚)
∗ 100%  
3.2.9 Antigen presentation assay 
Antigen presenting cells were isolated from the PBMCs of healthy HLA-DRB1*0101 
donors by magnetic isolation. Cells were seeded at 20 000 cells/well in 20 µl of hybridoma 
media in triplicate. The cells were rested in the incubator at 37°C 5%CO2 while the antigen 
coated beads were prepared. Selected wells were incubated with 50 µg/ml of chloroquine 
in hybridoma media for 1h. 
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The beads were prepared as follows: 50 µl of Dynabeads were transferred to a 1.5 ml 
microcentrifuge tube, the beads were washed 3x with 700 µl of cold Talon buffer using a 
Miltenyi biotec magnet to separate the magnetic beads from the supernatant. 50 µl of 
recombinant his-tagged M1 protein (2.2 mg/ml) were mixed with the beads and incubated 
on a roller for 5 min at RT. The beads were washed again 3x with cold Talon buffer. The 
beads were mixed with 50 µl of anti-M1 rabbit polyclonal serum and incubated for 5 min 
at RT. M1 protein and anti-M1 serum were a kind gift from Dr Paul Digard, University of 
Cambridge. The beads were washed 3x with 700 µl of Talon buffer and ressuspended in 
140 µl of warm hybridoma media and 5 µl were added per well. Antigen presenting cells 
were incubated with the beads for 1h. 
Selected wells then received a blocking anti-HLA-DR antibody or matched isotype control 
for 30 min. The hybridoma cells were pelleted at 300 g for 5 min at RT. The cells were 
ressuspended in warm hybridoma media and the concentration was adjusted to 1x106 
cells/ml. 20 µl of the hybridoma cell suspension were added per well. The cells were co-
cultured for 24h at 37°C 5%CO2. After 24h, the plates were spun at 300 g for 5 min at RT 
and the supernatants were collected. The supernatants were frozen at -20°C and read the 
next day with a mouse IL-2 ELISA and half-area ELISA plates (costar #3690). 
3.2.10 Statistical analysis 
Statistical analysis was performed with GraphPad Prism. Data were analysed with a one-
way ANOVA followed by Tukey’s correction for multiple comparisons. A p value ≤ 0.05 
was taken as statistically significant: p ≤ 0.05 = *, p ≤ 0.01 = **, p ≤ 0.001 = *. For all bar 
graphs, the mean ± SD is plotted.  
72 
 
4 Phagocytosis by γδ T cells 
4.1 Aims 
 Observation of γδ T cell phagocytosis by confocal microscopy 
 Quantification of γδ T cell phagocytosis by comparison with other leukocytes by 
o gentamicin protection assay 
o confocal microscopy 
o flow cytometry  
 Characterisation of phagocytic γδ T cells in terms of features shared with classical 
phagocytes in the blood such as reactive oxygen species production 
 Identification of distinguishing features between phagocytic and non-phagocytic γδ 
T cells such as cell surface markers and morphology 
4.2 Introduction 
Phagocytosis is a specialised process restricted to professional phagocytes. Professional 
phagocytes include monocytes, macrophages and dendritic cells and also 
polymorphonucleated cells such as neutrophils and eosinophils. 
Phagocytosis is an active endocytic process used for the uptake of particles more than 0.5 
µm in diameter. It is receptor-mediated and requires actin polymerization and 
reorganization (228;262). Phagocytic receptors include Fcγ receptors, complement 
receptors and mannose receptors. After internalisation the phagocytosed particle is 
contained in a phagosomal vesicle that fuses with lysosomes containing a variety of 
hydrolytic enzymes that kill and degrade microbes (263). Phagocytosis is used to clear 
pathogens such as bacteria or yeast, or large debris such as the remnants of dead cells (228).  
Phagocytosis was recently reported in a population of human blood γδ T cells (223). This 
intriguing observation supports the notion that γδ T cells may be evolutionarily ancient 
lymphocytes and could have implications on their role in the control of infection and 
cancer. This chapter describes experiments designed to better understand the relevance of 
phagocytosis by γδ T cells through the quantification of phagocytosis in these cells in 
parallel with other immune cells and attempting to isolate and characterise the phagocytic 
γδ T cell fraction. 
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4.3 Confocal microscopy of phagocytosis of opsonised fluorescein-labelled 
E. coli by γδ T cells 
Confocal microscopy is a useful tool for detecting γδ T cell phagocytosis as it allows for 
the direct observation of cell-scale processes and the staining of γδ TCR receptors. Both 
confocal microscopy and electron microscopy were previously used to evidence 
phagocytosis in freshly isolated γδ TCR+ cells (223). Since our lab did not have direct 
access to an electron microscope I decided to replicate the original qualitative confocal 
microscopy assay before developing it further as a quantitative one. In brief, γδ T cells were 
isolated to high purity (96-98%) by double column direct magnetic isolation from freshly 
isolated PBMC from healthy donors. They were mixed with fluorescein-labelled E. coli 
opsonised with anti-E. coli IgG antibodies and incubated on microscopy slides for 45 min 
at 37°C. The cells were stained for γδ TCR (magenta) and F-actin (red). In Figure 4.1 I 
show representative images of a phagocytosis experiment. This experiment was repeated 
in six donors with similar results (data not shown). 
Phagocytosis defined as green bacteria fully within the red actin border on z-stacks was 
observed in only a small proportion of γδ T cells. γδ T cells were frequently associated with 
bacteria, but most of these appeared to be bound to the cell surface (Figure 4.1, asterisks). 
Individual cells were imaged across several z-stacks to determine whether bacteria were 
inside the γδ T cell. On most z-stacks it was difficult to determine whether bacteria were 
surface-bound or internalised (Figure 4.3) but some appeared to show that the bacteria had 
been phagocytosed (Figure 4.2, white arrow). γδ TCR staining (magenta) was typically 
punctate which might be due to clustering of the anti-γδ TCR magnetic beads during the 
magnetic isolation procedure. In addition, γδ TCR staining was weaker on some cells. This 
is perhaps due to lower levels of γδ TCR expressed on some γδ T cell populations (as 
shown later in Figure 5.1) or the fact that most of the surface γδ TCR epitopes may already 
be occupied by the anti-γδ TCR magnetic beads used during the cell isolation step. 
In conclusion, evidence of phagocytosis as defined by internalisation of bacteria could be 
detected in γδ T cells freshly isolated from the blood of healthy donors. However, the 
proportion of γδ T cells found to phagocytose was small. In order to improve 
quantification of phagocytosis by γδ T cells I decided to explore the use of flow cytometry 
as described in the next section. 
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Figure 4.1 – Detection of phagocytosis of opsonised green fluorescent E. coli by γδ T cells using 
confocal microscopy 
To investigate whether human blood γδ T cells can phagocytose, freshly MACS isolated γδ T cells were 
incubated with IgG-opsonised fluorescein-labelled E. coli for 45 min at 37°C in polylysine coated slides in 
complete RPMI. The slides were then fixed, permeabilised and stained for γδ TCR (magenta) and F-actin 
(red) to visualise by fluorescence confocal microscopy. Individual cells can be identified by their fluorescent 
red cytoskeleton. Punctate γδ TCR staining can be observed in magenta in all cells. White arrows indicate 
phagocytosed E. coli. Asterisks denote bacteria bound to the γδ T cells but not internalised.   
75 
 
  
Figure 4.2 – Distinguishing intracellular E. coli from surface bound E. coli by confocal microscopy 
z-stacks 
Top to bottom z-stacks were taken of freshly isolated γδ T cells incubated with IgG-opsonised fluorescein-
labelled E. coli. Individual γδ T cells can be identified by their fluorescent red cytoskeleton. Punctate γδ 
TCR staining can be seen in magenta. Bacteria that appear on the top stacks but disappear when looking 
inside the cell may be bound but not internalised and are depicted with an asterisk. A white arrow indicates 
phagocytosed E. coli which are not visible on top of the cell but appear in the middle stacks. 
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Figure 4.3 – Examples of confocal microscopy z-stacks where the distinction between intracellular 
E. coli and surface bound E. coli is ambiguous 
Top to bottom z-stacks were taken of freshly isolated γδ T cells incubated with IgG-opsonised fluorescein-
labelled E. coli. Individual γδ T cells can be identified by their fluorescent red cytoskeleton. A white arrow 
indicates E. coli. γδ TCR staining in magenta is highlighted by removing red cytoskeleton fluorescence in 
the overlay on the bottom right pictures in A and B. A white arrowhead indicates punctate γδ TCR staining. 
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4.4 Quantification of phagocytosis by γδ T cells using a dual labelling flow 
cytometry assay 
Flow cytometry can be used to quantify phagocytosis using fluorescently labelled bacteria. 
One caveat is that bacteria adhering to the cell surface but not internalised will still be 
fluorescent. The fluorescence of externally adhered bacteria can be quenched using the 
vital dye trypan blue (264-266). This dye is incapable of penetrating intact cell membranes 
and so does not quench internalised bacteria. However, in initial experiments I found 
trypan blue quenching to be unreliable as quenched bacteria still appeared visibly green 
fluorescent under the fluorescent microscope (data not shown). In fact, different brands 
of trypan blue seem to vary significantly in their quenching abilities (266). 
A different option is to use the opposite approach, and fluorescently label only bacteria 
that are attached to the cell surface by staining with a fluorescently conjugated antibody 
after phagocytosis has taken place. To quantify phagocytosis I incubated freshly isolated 
γδ T cells with opsonised commercially available fluorescein-labelled E. coli in two 
independent experiments, one of which is shown in Figure 4.4. The non-engulfed bacteria 
were stained with an Alexa Fluor 405 (blue fluorescent) conjugated antibody. Cells that 
have phagocytosed fluorescein-labelled bacteria would be expected to emit green 
fluorescence, whereas cells that have only bound but not internalised fluorescein-labelled 
bacteria should emit both green and blue fluorescence. Samples of Alexa Fluor 405 stained 
and unstained bacteria were confirmed to fluoresce blue and green, or only green, 
respectively (Figure 4.4A). These were used to draw theoretical “bound E. coli” and 
“phagocytosed E. coli” gates. 
Freshly isolated γδ T cells were incubated with IgG-opsonised fluorescein-labelled E. coli 
for 45 min at 37°C. A control sample was kept on ice. Because phagocytosis is an active 
cellular process (228;262), low temperatures should significantly impair phagocytic 
function. By contrast, bacterial binding to the phagocyte surface should be less affected as 
it is a passive process. The purity of the γδ T cell fraction and the phagocytosis results are 
shown in Figure 4.4B. The purity of the fraction was very high (99.58% γδ TCR+). 
However, in accordance with the confocal microscopy experiments, very few γδ T cells 
were found to phagocytose. Fewer than 2% of γδ T cells were found to phagocytose using 
this test. However, one difficulty with this approach is that it is unable to discriminate 
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between phagocytic cells with bacteria attached and non-phagocytic cells with bacteria 
attached, as both would be double positive for blue and green. Therefore, phagocytosis 
might be underestimated. Also, the assay should be validated using a professional 
phagocyte positive control. In subsequent assays I have compared phagocytic function in 
γδ T cells in parallel with other cell types including professional phagocytes. 
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Figure 4.4 – Discrimination between intra and extracellular E. coli associated with γδ T cells using 
dual fluorescence flow cytometry 
To distinguish between phagocytosed bacteria and those bound to the outside of the cell membrane, a dual 
labelling technique was employed in which fluorescent E. coli are counter stained with another 
fluorochrome after phagocytosis has taken place. (A) Flow cytometry of green fluorescent E. coli (left) or 
of green fluorescent E. coli stained with a blue fluorescent antibody (right) in the absence of γδ T cells. (B) 
MACS isolated γδ T cells incubated with opsonised fluorescein-labelled E. coli at 37°C. A control sample 
was kept on ice to prevent phagocytosis. After 45 min co-culture, the non-internalised bacteria were 
counterstained with a blue fluorescent antibody. The histogram depicts γδ TCR staining in the MACS 
sorted fraction with the γδ T cell fraction in black and unlabelled PBMCs in grey. The dot plots are gated 
on γδ T cells and show green and blue fluorescence. γδ T cells with bacteria attached to the outer cell 
membrane should fluoresce green and blue (upper right quadrant) whereas γδ T cells that internalised 
bacteria but do not have any bacteria bound to their outer membrane should fluoresce only green (upper 
left quadrant). γδ T cells with no bacteria should appear in the bottom left quadrant. 
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4.5 GFP-expressing live E. coli can be used to quantify phagocytosis 
The commercially available lyophilised and fluorescein-labelled E. coli preparation used in 
the experiments described so far has also been widely used in phagocytosis assays in the 
literature (267-272). However, a number of drawbacks became evident in the course of my 
experiments. These green fluorescent E. coli bled strongly into the orange-red channels and 
were so intensely fluorescent that they did not allow for the accurate fluorescence 
compensation that is needed for multiparameter flow cytometry. In addition, phagocytosis 
is defined as the receptor-mediated uptake of large particles (228;262), but visualisation of 
these E. coli by confocal microscopy showed that they tend to break down into smaller 
pieces (Figure 4.1) which is likely to be a consequence of the heat inactivation and 
lyophilisation processes used during its manufacture. To better evaluate phagocytosis I 
acquired live E. coli expressing gfpmut3α, a wavelength-shifted enhanced mutant of wild type 
green fluorescent protein (GFP) (273;274) which could be grown in the lab before each 
phagocytosis experiment. I confirmed the morphology and fluorescence of a preparation 
of opsonised GFP-expressing E. coli by confocal microscopy (Figure 4.5A). The bacteria 
fluoresced green and displayed a rod-like morphology and size typical of intact E. coli bacilli. 
To ensure standardisation between experiments it is important to add the same ratio of 
bacteria per mammalian cell each time an experiment is performed, so, it is necessary to 
have a means of quantifying bacterial cell numbers. The turbidity of bacterial cultures is 
directly proportional to the bacterial cell concentration during the log phase of expansion. 
Therefore, I generated a standard curve by measuring the optical density at 600 nm (OD 
600) and the number of colony forming units (CFU) from samples taken from a freshly 
inoculated culture of GFP-expressing E. coli every hour for eight hours (Figure 4.5B). 
Samples were analysed for OD 600 by spectrometry and for colony forming units (CFU) 
by serial dilution, seeding onto LB agar plates containing ampicillin, and counting colonies 
the next day. The concentration of the bacterial cultures was calculated from the number 
of colonies on the plate according to the following equation: 
𝐶𝐹𝑈
𝑚𝑙
=
𝑛𝑜. 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 x 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝑣𝑜𝑙𝑢𝑚𝑒 𝑝𝑙𝑎𝑡𝑒𝑑
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By plotting OD 600 vs CFU/ml I generated a standard curve that was used in the following 
phagocytosis assays to ensure the same number of GFP-expressing E. coli was added per 
sample. 
Phagocytosis of lyophilised fluorescein-labelled E. coli and GFP-expressing E. coli was 
compared in one donor by a blindly-scored confocal microscopy assay. The two types of 
E. coli were opsonised with IgG and incubated for 45 min with γδ T cells, αβ T cells, NK 
cells and monocytes isolated from PBMC. The slides were then fixed and the cells were 
stained for F-actin and nuclei, and observed by confocal microscopy. 100 images per cell 
type were taken. The images were blinded and randomised using the RenameRandom 
software described in section 4.7 before being scored. The vast majority of monocytes 
phagocytosed both types of E. coli. Although the percentage of phagocytosing monocytes 
was lower with GFP-expressing E. coli than with lyophilised fluorescein-labelled E. coli 
(Figure 4.6A), a larger proportion of monocytes had bacteria bound to the cell surface but 
not internalised with GFP-expressing E. coli (Figure 4.6B). A possible explanation for this 
observation is that both types of bacteria are subject to phagocytosis but that it takes longer 
for live GFP-expressing E. coli to be engulfed than for the lyophilised fluorescein-labelled 
E. coli. NK cells are known to express high levels of the Fcγ receptor CD16 and were 
observed to strongly bind both types of IgG coated bacteria suggesting opsonisation with 
the anti-E. coli IgG antibodies was successful. More significantly, the type of E. coli used 
resulted in no observable difference in the number of γδ T cells undergoing phagocytosis 
or binding (Figure 4.6).  
In conclusion, both types of E. coli were strongly phagocytosed by professional phagocytes 
and equally phagocytosed by γδ T cells. I decided to replace the commercially available 
lyophilised fluorescein-labelled E. coli used in the previous phagocytosis assays with live 
GFP-expressing E. coli which offer numerous advantages, particularly a more manageable 
fluorescence intensity that allows for multiparameter flow cytometry and a morphology 
which better resembles that of the bacteria the immune system is likely to encounter during 
infection.  
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Figure 4.5 – Establishment of live GFP-expressing E. coli cultures as an alternative to lyophilised 
fluorescein-labelled E. coli for the study of phagocytosis in γδ T cells 
E. coli containing a plasmid for GFP expression under the control of the LacZ promoter were investigated 
as an alternative to the lyophilised fluorescein-labelled E. coli. (A) E. coli cultured overnight in LB broth with 
IPTG to induce expression of GFP were visualised by confocal microscopy (left). Plasmid map for GFP 
expression under the control of the LacZ promoter (right). (B) A standard curve was constructed in order 
to estimate bacterial concentrations from OD 600 readings. Samples were taken from a freshly inoculated 
culture every hour for eight hours. All samples were tested for OD 600 and then diluted and seeded onto 
LB agar plates with ampicillin to count colony forming units (CFU). Bacterial growth is shown over time 
as measured by OD 600 (dark grey line) and CFU/ml (light grey line). Values for OD 600 and CFU/ml 
were taken from the log phase period and used to build a standard curve. This standard curve was used to 
calculate the concentration of bacterial cultures in order to standardise phagocytosis assays.  
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Figure 4.6 – Comparing phagocytosis of lyophilised fluorescein-E. coli and live GFP-E. coli 
by confocal microscopy 
The phagocytosis assays described in this chapter were performed with either fluorescein-labelled 
lyophilised E. coli (K-12 strain) or live GFP-expressing E. coli (DH5α strain). To test whether the type 
of E. coli used affected the efficiency of phagocytosis both bacteria were tested in parallel in a blindly-
scored comparative phagocytosis assay using confocal microscopy. Four cell types were purified from 
the same donor’s PBMCs by MACS. Opsonised E. coli were added for 45 min at 37°C. The slides 
were washed and fixed and stained for F-actin and nuclei. 100 images per slide were taken. The images 
were blindly-scored using randomising software. Phagocytosed and surface-bound bacteria were 
counted with the cell counter plugin in the microscopy software Image J. The bar charts show the 
proportion of cells displaying (A) phagocytosed or (B) surface-bound bacteria. 
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4.6 Internalisation of opsonised live E. coli by γδ T cells can be detected in 
a standard gentamicin protection assay 
One advantage of using live E. coli for phagocytosis experiments is that a wider range of 
assays can be used. One such is the gentamicin protection assay which is a standard 
microbiology technique used to measure invasion of mammalian cells by bacteria. This 
assay takes advantage of the fact that gentamicin efficiently kills Gram-negative bacteria 
but does not enter most mammalian cells including immune cells. The mechanism by which 
gentamicin is able to enter some mammalian cells is unclear but appears to be restricted to 
kidney epithelial cells and inner ear sensory hair cells, leading to kidney failure and hearing 
loss in some patients on gentamicin (275). In the gentamicin protection assay, internalised 
bacteria are distinguished from surface-bound bacteria by the addition of gentamicin to the 
culture media after phagocytosis. The antibiotic kills the bacteria that have not been 
internalised and hence are not protected from its action. 
To confirm bacteria were internalised by γδ T cells I performed a standard gentamicin 
protection assay (Figure 4.7). Monocytes were used as a positive control for phagocytosis. 
Freshly isolated γδ T cells or monocytes were incubated with opsonised GFP-expressing 
E. coli. Non-phagocytosed bacteria were then killed by adding gentamicin to the culture 
media. The mammalian cells were pelleted and lysed. The lysed cell pellet was diluted and 
seeded onto LB agar plates with ampicillin to count bacterial colony forming units (CFU) 
the next day.  
Colonies could be seen both in the γδ T cell lysates and in the monocyte lysates but not in 
supernatants containing gentamicin (Figure 4.7A) confirming that non-internalised bacteria 
were efficiently killed. To understand how the ability of γδ T cells to phagocytose compares 
to that of a professional phagocyte I performed experiments varying the ratio of bacteria 
to phagocyte added. Between 104 and 107 bacteria were added to 105 freshly isolated γδ T 
cells or monocytes (a ratio of 0.1-100 bacteria per leukocyte). This experiment was repeated 
twice with similar results. One such experiment is shown in Figure 4.7B. A dose-dependent 
response was observed in both monocyte and γδ T cell wells. The assay could detect 
phagocytosis with a minimum of 1 E. coli per monocyte. However, a ratio of 100 E. coli per 
leukocyte was needed to detect phagocytosis in γδ T cells. This data can be interpreted in 
a number of ways. It is possible that γδ T cells are able to phagocytose but do so with 
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significantly less proficiency than classical phagocytes. Another possibility is that a small 
proportion of cells in the γδ T cell fraction are phagocytic. These phagocytic cells could be 
contaminating cells that are not γδ T cells but are present in the highly purified γδ T cell 
fraction or alternatively could be a rare and as yet uncharacterised population of phagocytic 
CD3+ γδ TCR+ cells. A third possibility is that phagocytic γδ T cells, like neutrophils, 
destroy bacteria quickly once internalised and hence would not be detected in the 
gentamicin protection assay as this only measures viable bacteria. 
Three independent experiments using a ratio of 100 bacteria to 1 leukocyte showed 
phagocytosis in γδ T cell wells (Figure 4.7C). The first two experiments only show γδ T 
cells and monocytes, whereas the third also includes αβ T cells. Phagocytosis by γδ T cells 
was detected in all experiments. On average, lysates from γδ T cells contained 144 CFU/104 
leukocytes whereas monocytes contained 806 CFU/104 leukocytes and αβ T cells 10 
CFU/104 leukocytes. The purity of the fractions as measured by flow cytometry was on 
average 96.72% ± 0.65 for γδ T cells, 96.33% ± 1.90 for monocytes and 98.74% for αβ T 
cells (data not shown). Although the purity of the fractions is high, we cannot rule out the 
possibility that a phagocytic response could come from the 2.63-3.93 % non-CD3+ γδ 
TCR+ flow cytometry events present in the γδ T cell fraction. 
The gentamicin protection assay shows that IgG-opsonised intact bacteria can be 
internalised by cells in the γδ T cell fraction as lysates from these cells give rise to bacterial 
colonies albeit with lower efficiency than monocytes. However, since it is a bulk assay it is 
not possible to observe whether a small proportion of cells in the γδ T cell fraction engulfed 
many bacteria each or whether a larger proportion of cells engulfed a small number of 
bacteria each. In order to be able to discern this a microscopy or flow cytometry-based 
method could be used. This assay also confirms that GFP-expressing live E. coli can be 
used reliably to assess phagocytosis in professional phagocytes. Building on these findings, 
I then developed quantitative microscopy and flow cytometry approaches to quantify the 
proportion of γδ T cells that phagocytose.  
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Figure 4.7 – Internalisation of opsonised live E. coli by γδ T cells is detected in a standard gentamicin 
protection assay 
Gentamicin does not penetrate mammalian cells and so can be used to distinguish between non-susceptible 
bacterial cells inside mammalian cells and susceptible bacterial cells that are attached to the surface. To 
investigate whether γδ T cells can internalise live bacteria and to compare their phagocytic ability to that of 
professional phagocytes, γδ T cells and monocytes were purified by MACS and assayed in parallel. Leukocytes 
were incubated with opsonised live bacteria for 45 min, washed and incubated with gentamicin. The leukocytes 
were washed and lysed and lysates were seeded onto ampicillin LB agar to count bacterial colony forming units 
(CFU). (A) Example of CFU from a γδ T cell lysate, a monocyte lysate and the gentamicin-containing 
supernatant. (B) Varying numbers of bacteria were added to compare the phagocytic ability of γδ T cells and 
monocytes and to test for the lower limit of detection of the assay. (C) Three independent assays with the same 
ratio of 100 bacteria per phagocyte comparing γδ T cells and monocytes tested in parallel. Each symbol 
represents CFU from one well. Experiment 3 also includes αβ T cells. 
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4.7 Comparative quantification of phagocytosis of highly purified leukocyte 
fractions using blind scoring of confocal microscopy images 
The purity of the cell fraction is a constant concern when assessing phagocytosis in non-
classical phagocytes. Direct magnetic isolation through two sequential columns routinely 
yields very high purities (96-98%) for γδ T cell preparations but the number of 
phagocytosing γδ T cells apparent by confocal microscopy is also very low. Therefore, to 
assess phagocytosis in a purer preparation of human γδ T cells, I decided to further purify 
magnetically isolated cells by FACS sorting before challenging them with bacteria and 
quantifying phagocytosis by confocal microscopy. Two independent experiments were 
performed with similar results. Examples from one experiment are shown in Figure 4.8A 
and 4.8B and the pooled results from the two experiments are shown in Figure 4.8C. 
The purity of the cell fractions before FACS sorting was already high: 96.95% for γδ T 
cells, 98.26% for αβ T cells, 88.18% for NK cells and 98.76% for monocytes as measured 
by flow cytometry (Figure 4.8A). Note FSC x SSC shows absence of monocytes in the γδ 
T cell fraction. Unlike the other cell types, NK cells were isolated by negative rather than 
positive selection hence the comparatively lower purity of the fraction. In order to ensure 
that adequate numbers of cells were available for the phagocytosis assay I did not measure 
cell purity after FACS sorting. However, cell purity would be expected to be at least as high 
after sorting as before. 
The cell fractions were incubated with opsonised GFP-expressing E. coli at 37°C for 45 
min to allow for phagocytosis. Afterwards, the samples were fixed and stained for F-actin 
(red) and nuclei (blue). Although all lymphocytes were previously stained with antibodies 
against γδ TCR, αβ TCR and CD56 for FACS sorting, the same fluorochrome (PE) was 
chosen in order to avoid any chance of identifying the cell type during blind scoring of 
images. Similarly, the Alexa Fluor 555 dye used for F-actin overlaps with PE masking its 
staining. The dye APC was also chosen for CD3 for FACS sorting as it emits in infrared 
and therefore can easily be excluded from acquisition on the confocal microscope in this 
assay.  
100 images per cell type were taken in the confocal microscope. The images were 
anonymised and randomised using the RenameRandom software before being scored. 
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Each image was scored using the cell counter plugin in the microscopy analysis software 
Image J (Figure 4.8B shows an example). After scoring, the pictures were cross-referenced 
back to their original name. This automated blinding was employed in order to prevent 
observer bias as microscopy techniques are inherently subjective. The software 
RenameRandom was purpose-built by Flávio J. Saraiva (Department of Informatics 
Engineering, University of Coimbra, Portugal). During confocal microscopy the user keeps 
the ZEISS LSM 5 default data file name whilst saving the images, resulting in filenames 
such as “Image1.lsm”, “Image2.lsm”, and so on. When RenameRandom is run in the 
directory containing the image files it replaces the numbers in the file names with random 
numbers and creates a key containing original and randomised file names as a CSV file. 
The renamed image files are then ordered by name and hence become randomised. The 
user then manually scores the image files and saves these scores in an Excel spreadsheet. 
After scoring, the key is pasted into the Excel spreadsheet and the rows are reordered 
according to the original file names using the “Sort & Filter” command, thereby unblinding 
the data. This simple bioinformatics tool can be used by individual researchers wishing to 
score images blindly without the need for two different people to perform data acquisition 
and scoring. 
An average of 923 cells for each cell type was scored (range 722-1292). Average results 
from two independent experiments are shown in Figure 4.8C. γδ T cells were not found to 
phagocytose significantly more frequently than any of the other lymphocytes tested in the 
same assay. In both donors, a small number of lymphocytes were found to phagocytose 
(average 2.50% of γδ T cells, 0.75% of αβ T cells and 1.70% of NK cells) as well as a large 
number (average 59.09%) of monocytes. On average, 4143 cells were individually scored 
per experiment. Of these, an average of 5 αβ T cells, 16 NK cells, 32 γδ T cells and 642 
monocytes were blindly scored as phagocytic.  
Phagocytosis in γδ T cells may be restricted to a particular subtype of γδ T cells, for 
instance, γδ T cells expressing the CD16 receptor which could mediate binding to IgG 
opsonised bacteria (223). However, a much greater percentage of γδ T cells in healthy 
blood express CD16 than those that were found to phagocytose and NK cells, which stain 
brightly for CD16 were not phagocytic either. 
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Another possibility is that mechanical manipulation of the cells by both magnetic isolation 
and FACS could have negatively impacted the functional activity of the cells. To try to 
estimate the possible impact of this effect one can look at the literature as monocyte 
phagocytosis has been extensively characterised. Typically, in tests using opsonised FITC-
labelled E. coli, researchers have reported between 57.1% and 80% monocyte phagocytosis 
after only 10 min at 37°C using untouched whole blood samples from healthy adults (276-
278). In the assay depicted in Figure 4.8, monocytes phagocytosed between 47.80 and 
70.37% after a 45 min incubation and after extensive purification with both MACS and 
FACS. Therefore, the phagocytosis found for monocytes in this assay is lower than the 
levels usually reported by other scientists, but not substantially so. 
These data suggest that γδ T cell phagocytosis can be observed but is a rare phenomenon. 
Because it is so rare it is difficult to confidently ascertain whether this phagocytosis is 
performed by true γδ T cells or contaminating cells in the γδ T cell fraction. However, it 
should be noted that γδ TCR staining is visible in the confocal microscopy slides depicting 
phagocytosis in Figures 4.1-4.3. In order to address the possibility of contaminating cells 
in the γδ T cell fraction I decided to test phagocytosis in fresh blood samples without a γδ 
T cell isolation step and performed γδ T cell staining afterwards. This work is described in 
the following section.  
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Figure 4.8 – Comparative quantification of phagocytosis of highly purified leukocyte fractions 
using blind-scored confocal microscopy images 
This assay was designed to compare the phagocytic function of γδ T cells with other lymphocytes and 
professional phagocytes. γδ T cells, αβ T cells, NK cells and monocytes were all isolated by MACS 
separately from the same donor’s PBMCs. (A) Purity of the MACS isolated fractions. The cells were then 
further purified by FACS. All cell types were co-cultured with opsonised live GFP E. coli on slides for 45 
min at 37°C. The slides were fixed and stained for F-actin (red) and nuclei (blue). 100 pictures per slide 
were taken. The pictures were blinded using RenameRandom and scored using the cell counter plugin in 
Image J. (B) Example of a confocal microscopy image and scoring using the counting plugin. 1 = no 
phagocytosis, 2 = surface-bound bacteria, 3 = phagocytosis. (C) Phagocytosis by the four different cell 
types. Average of two independent experiments performed with different donors. 
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4.8 A population of CD3+ γδ TCR+ cells in whole blood can phagocytose 
opsonised GFP-expressing E. coli 
The results described so far showed that small numbers of γδ T cells can be found to 
phagocytose in purified γδ T cell preparations but that this response is not significantly 
different from that of other lymphocyte preparations. A possible interpretation of the data 
is that phagocytosis may be performed by cells in the average 2% contaminating cells 
present in γδ T cell preparations that may also presumably be found in αβ T cell and NK 
cell preparations. However, the phagocytic γδ T cells in the images in Figures 4.1-4.3 
showed positive γδ TCR staining. 
In order to avoid the problem of contaminating cells in γδ T cell preparations, a novel assay 
was developed that tests the phagocytic potential of γδ T cells in unprocessed blood 
samples. Since γδ T cells are only a minor fraction of blood leukocytes (1-5% of PBMC, 
PBMC are approximately 30% of leukocytes), screening a statistically significant number 
of γδ T cells by confocal microscopy would be prohibitively labour-intensive and the 
samples are analysed instead by flow cytometry. This assay uses whole blood samples that 
are challenged with bacteria within 30 min of blood collection. 5 ml of blood were drawn 
from healthy volunteers and separated into five tubes. Opsonised GFP-expressing live E. 
coli and blood were cooled on ice separately for 10 min. Bacteria were then added to all 
tubes at a ratio of 100 bacteria per leukocyte and four tubes were moved to a 37°C 
waterbath while the fifth tube was kept on ice. After 30 min incubation at 37°C, all tubes 
were placed on ice where they were stained with antibodies against the γδ TCR, αβ TCR, 
CD3, CD14 and CD56. All antibodies were directly conjugated to fluorochromes with no 
spectral overlap to GFP (eFluor450 and APC) in order to prevent false positive results. 
The samples were fixed and red blood cells were lysed with a one-step RBC lysis reagent 
from the PHAGOTEST kit (Orpengen, Germany). The samples were run in an LSRII 
flow cytometer within an hour. The same experiment was repeated a total of five times, 
each time with a different healthy donor. One representative experiment is shown in Figure 
4.9A and the results from all the experiments are pooled in Figure 4.9B. 
Figure 4.9A shows a representative experiment. The top plots are from the ice control. On 
the left is the ice control scatter plot with evidence of 3 populations typically recognisable 
by light scatter: lymphocytes with smaller FSC and SSC, monocytes with increased FSC 
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and SSC and granulocytes with the highest SSC. Light scatter in flow cytometry is 
proportional to the size and granularity of the cell type, with larger cell types having larger 
FSC and more granular cell types having higher SSC. The histogram next to the ice control 
scatter plot shows fluorescence in the GFP gate by ungated cells in the ice control and was 
used to draw a “GFP-E. coli+” gate. 
The gating strategies and GFP fluorescence of all four cell types assayed are displayed in 
Figure 4.9A. Gating of γδ T cells based on CD3+ γδ TCR+ showed the typical two 
populations of γδ T cells in the blood, expressing different levels of TCR (see Figure 5.1 
for other examples). A proportion of γδ T cells (average 12.21%, range 5.00% to 21.32%) 
appears to have phagocytosed opsonised GFP-expressing E. coli. αβ T cells were gated 
based on CD3+ αβ TCR+ and NK cells were gated based on CD3- CD56+. Phagocytosis 
by αβ T cells and NK cells was not detected in this assay. Although this assay does not 
specifically distinguish between bound and internalised bacteria, IgG opsonised E. coli only 
associated weakly with NK cells (average 1.35%, range 0.20% to 2.61%). This suggests that 
the apparent phagocytosis seen in the γδ T cell gate should not be a consequence of bacteria 
bound to the outside of γδ T cells via CD16 receptors, as otherwise it would be apparent 
in the NK cell gate as well. Monocytes were gated based on CD14+. Monocytes took up 
bacteria significantly more frequently than any other cell type (average 74.59%, range 
67.20% to 83.05%). Among all lymphocyte populations tested, CD3+ γδ TCR+ cells in 
whole blood phagocytosed bacteria significantly more frequently. Interestingly, the MFI of 
phagocytosing CD3+ γδ TCR+ cells resembled that of phagocytosing monocytes, 
suggesting that the number of bacteria taken up per cell was similar. It should be noted 
that all tests were performed on whole blood, therefore any phagocytosis observed 
happened in competition with professional phagocytes present in the blood. Therefore, 
phagocytosis by γδ TCR+ cells is not only observed when these cells are purified from 
blood samples and tested in isolation. This whole blood phagocytosis assay has many 
strengths. Because the cell processing steps have been removed, the cells are assayed very 
quickly after blood collection which gives us greater confidence that they retain their 
physiological characteristics. In addition, although the assay does not distinguish between 
internalised and attached bacteria, it does include an ice control and all the different cell 
types are tested in parallel. It should also be noted that this assay was adapted from a 
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clinically-relevant test (PHAGOTEST, Orpengen), which is used at Great Ormond Street 
Hospital to help diagnose neutrophil disorders in paediatric patients (21;279).  
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Figure 4.9 – A population of CD3+ γδ TCR+ cells in whole blood can phagocytose opsonised GFP-
expressing E. coli 
Testing for γδ T cell phagocytosis under conditions of minimal experimental manipulation of cells. Freshly 
drawn heparinised blood was separated into 5 FACS tubes to which opsonised GFP-expressing E. coli were 
added. 4 tubes were transferred to a 37°C waterbath. After 30 min, the tubes were placed on ice and stained. 
Each tube was stained for different markers to identify either γδ T cells (CD3 and γδ TCR), αβ T cells (CD3 
and αβ TCR), NK cells (CD3 and CD56) or monocytes (CD14), except the ice control which was left 
unstained. Samples were RBC lysed and fixed and analysed by flow cytometry. (A) Example of data analysis 
from one experiment. Top plots: ice control GFP fluorescence is used to draw the phagocytosis gate. Middle 
plots: gating strategies for the four cell type. Bottom plots: GFP fluorescence gated on each cell types. (B) 
Pooled results from five independent experiments with separate donors. 
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In the flow cytometry experiments depicted in Figure 4.9 a population of CD3+ γδ TCR+ 
cells present in the blood phagocytosed opsonised GFP-expressing E. coli. I gated on 
phagocytic and non-phagocytic CD3+ γδ TCR+ cells to see if any differences could be 
seen between the two in terms of surface staining and light scatter profile (Figure 4.10). 
CD3+ γδ TCR+ cells were gated as shown in Figure 4.9 and divided into non-phagocytic 
and phagocytic populations based on GFP fluorescence (GFP histogram, Figure 4.10A). 
Phagocytic and non-phagocytic cells were present in both the CD3+ γδ TCRhigh and the 
CD3high γδ TCRlow usual sub-populations of γδ T cells (CD3 and γδ TCR histograms, 
Figure 4.10A; see Figure 6.1 for other examples of γδ T cell sub-populations). These 
observations argue against the possibility of the apparent γδ T cell phagocytosis being a 
consequence of unspecific granulocyte fluorescent background because the phagocytic γδ 
T cells segregated clearly into two populations. In addition, they show that there is no 
detectable relationship between TCR expression level and the frequency of phagocytosis. 
Interestingly, CD3+ γδ TCR+ cells in whole blood segregated into two clearly distinct 
populations by light scatter. The top left dot plot in Figure 4.9A shows the light scatter of 
an ungated whole blood sample. Typical lymphocyte, monocyte and granulocyte 
populations are visible with increasingly higher forward scatter (FSC) and side scatter 
(SSC). This is because FSC is proportional to cell-surface area and SSC is proportional to 
granularity (280). Therefore, lymphocytes generally appear as small smooth cells, 
monocytes are larger and granulocytes have abundant intracellular granules that strongly 
refract light. Figure 4.10 shows all gated CD3+ γδ TCR+ cells in a light scatter dot plot. A 
majority of the cells display the typical light scatter profile of a lymphocyte. However, a 
significant proportion of CD3+ γδ TCR+ cells in whole blood have the same light 
scattering properties as granulocytes. Gating on “granular CD3+ γδ TCR+ cells” and 
“normal CD3+ γδ TCR+ cells” revealed the former were virtually all phagocytic whereas 
the latter were entirely non-phagocytic (Figure 4.10B). 
These results can be interpreted in two ways. Firstly, the cells may appear granular because 
they have engulfed bacteria. However, phagocytic monocytes did not show a similar 
increase in SSC (data not shown). Secondly, the cells may indeed be a distinct granular 
CD3+ γδ TCR+ population. The fact that previous experiments in this chapter did not 
find a significant difference in phagocytosis between different lymphocytes would be in 
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agreement with granulocyte phagocytic CD3+ γδ TCR+ cells since these would be 
excluded from PBMCs, which were used as a source of cells for γδ TCR+ MACS selection 
in these previous experiments. Although granulocytes are known to layer with PBMCs in 
certain situations such as particular disease states (281;282), older blood samples or 
cryopreserved blood samples (283;284), in general they are excluded from PBMC fractions 
during density gradient separation. 
This assay cannot distinguish between these two possibilities because flow cytometry takes 
place after phagocytosis. Therefore, it does not inform us as to whether phagocytic CD3+ 
γδ TCR+ cells in whole blood are granular cells or appear granular because they have 
engulfed bacteria. The following experiments attempt to further characterise this 
phagocytic CD3+ γδ TCR+ population present in the blood of all donors tested. 
  
97 
 
  
Figure 4.10 – Characteristics of phagocytosing and non-phagocytosing CD3+ γδ TCR+ cells in the 
whole blood phagocytosis assay 
Further analysis of the flow cytometry data in the γδ T cell gate in the phagocytosis whole blood assay 
described in Fig. 4.9. (A) The histogram on the left is gated on γδ T cells as shown in Fig. 4.9A and shows 
a negative and a positive population for GFP-E. coli, labelled non-phagocytic and phagocytic, respectively. 
The histograms on the right depict CD3 and γδ TCR fluorescence. The phagocytic fraction is shown in 
green and the non-phagocytic fraction in black. (B) The dot plot on the left is gated on γδ T cells as shown 
in Fig. 4.9A and shows FSC x SSC. Two populations can be distinguished based on light scatter properties, 
one labelled “normal CD3+ gamma delta TCR+ cells” in a typical lymphocyte gate and one labelled 
“granular CD3+ gamma delta TCR+ cells” in a typical granulocyte gate. The histogram on the right depicts 
GFP-E. coli fluorescence in the “normal CD3+ gamma delta TCR+ cells” gate in black and in the “granular 
CD3+ gamma delta TCR+ cells” in green. 
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4.9 Phagocytosing CD3+ γδ TCR+ cells in whole blood produce reactive 
oxygen species 
Professional phagocytes such as macrophages and neutrophils produce reactive oxygen 
species (ROS) to destroy ingested microbes (285). ROS production is essential for 
antimicrobial defence. Neutrophils from patients with chronic granulomatous disease 
(CGD) are deficient in the NADPH oxidase system that generates superoxide and are 
unable to kill many strains of bacteria, yeast, and fungi. These same patients suffer severe 
infections (286). CGD is diagnosed by the demonstration of deficient respiratory burst 
activity in phagocytic cells. The oldest and most widely used assay is the nitroblue 
tetrazolium (NBT) test (287). The NBT test assays the ability of activated neutrophils to 
produce superoxide, which reduces the yellow water soluble NBT dye to insoluble blue 
formazan. Therefore, a functional respiratory burst is demonstrated by the presence of a 
dark blue precipitate within the cell evident under light microscopy. 
To investigate whether phagocytic CD3+ γδ TCR+ cells were capable of a functional 
respiratory burst, phagocytic and non-phagocytic CD3+ γδ TCR+ cells and neutrophils 
were FACS sorted from the same blood sample and assayed in a functional NBT test. 
Whole blood was incubated with opsonised GFP-E. coli for 30 min at 37°C and then 
stained on ice for CD3 and γδ TCR. RBC were lysed with fixative-free ammonium chloride 
buffer. The cells were directly FACS sorted onto flat 96-well plates containing complete 
culture media. After FACS sorting, NBT dye was added to the wells and the cells were 
incubated at 37°C for 30 min. EDTA was added to quench the reaction and pictures were 
taken by light microscopy (Figure 4.11). 
Blue formazan precipitates were clearly visible in phagocytic CD3+ γδ TCR+ fractions but 
absent from the non-phagocytic CD3+ γδ TCR+ fractions. Reactive oxygen species 
production by phagocytic γδ T cells was approximately one-third that of neutrophils in the 
two donors were tested. Overall, these results suggest that the CD3+ γδ TCR+ population 
in the blood that is phagocytic towards opsonised E. coli is capable of a functional 
respiratory burst, as would be expected for a professional phagocyte. 
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Figure 4.11 – Phagocytosing CD3+ γδ TCR+ cells in whole blood produce reactive oxygen species 
NBT assay to investigate whether phagocytic γδ T cells have an oxidative burst. Neutrophils, phagocytic 
and non-phagocytic CD3+ γδ TCR+ cells were isolated by FACS sorting from whole blood incubated with 
opsonised GFP-expressing E. coli. FACS sorted cells were seeded into flat-bottom 96-well plates with 
complete media and incubated with NBT dye for 30 min at 37°C. The yellow NBT dye is ingested by the 
cells and, in the presence of reactive oxygen species, converted to the purple-blue formazan compound. 
Pictures were taken by light microscopy. The quantification of NBT+ cells is shown. Average of 2 
independent donors. 
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4.10 Phagocytosing CD3+ γδ TCR+ cells in whole blood have unusual 
morphology 
Histological staining is a simple procedure that enables visual discrimination of cell 
contents on the basis of different propensities to take up a given stain. The stains typically 
allow discrimination between the nucleus and the cytoplasm and can also provide 
information about the content of intracellular granules. Therefore, cell samples can be 
easily described in terms of nuclear morphology, the size of the cytoplasm, or the presence 
of specific granules. 
In their resting state, human blood γδ T cells appear smooth and round, are approximately 
7-12 µm in diameter, and possess a central circular nucleus surrounded by a small volume 
of cytoplasm. When activated they appear, as do activated αβ T cells, much larger with 
more irregular and granular shapes (288). CD16+ αβ T cells in the blood of healthy donors 
have been described as having the appearance of activated lymphocytes with a large 
granular lymphocyte morphology (289). Skin-resident γδ T cells also appear larger and 
show a dendritic-like morphology (290). Rare dendritic-like γδ T cells have also been 
described in human blood from healthy donors (223). An example of this was shown earlier 
in this chapter and is highlighted in Figure 4.12. Dendritic-like extensions are evident by 
F-actin staining (red) and γδ TCR staining is also present (magenta). 
Figure 4.12 - Human blood γδ T cells 
include cells with unusual dendritic-like 
extensions 
γδ T cells freshly isolated from healthy donor 
PBMCs by MACS. F-actin (red) and γδ TCR 
(magenta) staining. White arrows indicate 
dendritic-like extensions. 
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To investigate the morphology of phagocytosing and non-phagocytosing CD3+ γδ TCR+ 
cells, whole blood was incubated with opsonised E. coli, stained with anti-CD3 and anti-γδ 
TCR antibodies and the two populations were FACS sorted. The sorted cells were 
cytospun onto slides and stained with Diff-Quick. They were then scored as small 
lymphocytes, large lymphocytes, monocytes or polymorphonucleated cells according to 
their morphology, specifically nuclear morphology (circular, kidney-shaped or 
polymorphonuclear) and cytoplasm to nucleus ratio (small or large cells). The images in 
Figure 4.13 show representative examples. Small lymphocytes include Figure 4.13A and J. 
Large lymphocytes include Figure 4.13B, F and H. Polymorphonucleated cells are shown 
in Figure 4.13C, D, E and G, and a monocyte is shown in I. The plots in Figure 4.13K and 
L show the pooled results of three independent experiments, each with a different healthy 
donor. 
The results from each of the three experiments were strikingly similar. Virtually all non-
phagocytic CD3+ γδ TCR+ cells had the unequivocal morphology of a lymphocyte, with 
a round shape containing a nucleus surrounded by a small volume of cytoplasm. However, 
phagocytic CD3+ γδ TCR+ cells were a heterogeneous population. The largest group was 
composed of polymorphonucleated cells, with either a bi-lobed, tri-lobed or multilobed 
nucleus. The only cells described in the blood with this nuclear morphology are eosinophils 
(bi-lobed), basophils (bi-lobed or tri-lobed) and neutrophils (multilobed). 
Intriguingly, the presence of a CD3/γδ TCR has been described in polymorphonucleated 
cells before. Puellmann et al showed the presence of various components of the TCR 
complex including each of the TCR α, β, γ and δ constant regions by RT-PCR and Western 
blot in human granulocyte preparations containing 97% neutrophils (291). Other 
granulocytes like eosinophils are also present in granulocyte fractions isolated with the 
same method (Figure 4.17). Indeed, a subsequent paper by a different group found no 
CD3/γδ TCR on neutrophils purified from granulocyte preparations but did find a 
functional CD3/γδ TCR complex in eosinophils from the same donors (292). Puellmann 
recently reported again the expression of a CD3/γδ TCR receptor in human monocytes 
and macrophages (293). 
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Only 1% of the phagocytic CD3+ γδ TCR+ cells showed monocyte morphology, as shown 
in Figure 4.13I, with a kidney shaped nucleus. The largest group (41.67%) of phagocytic 
CD3+ γδ TCR+ cells were polymorphonucleated cells. Additionally, 20.33% of the 
phagocytic cells observed had a round nucleus and a large cytoplasmic body, similar to 
activated T cells. It should be noted that the phagocytosis experiment takes place less than 
30 min after the blood was drawn and the FACS sorting takes place around 2h30 after the 
start of the experiment, so these cells have been cultured ex vivo for a minimal amount of 
time and should have phenotypes similar to those of cells circulating in healthy blood. 
Finally, 24.87% of the phagocytic cells resembled normal T cells, with a round nucleus and 
a small cytoplasmic volume, but with bacteria evident in the cytoplasm. These may 
correspond to the rare phagocytic γδ T cells present in PBMCs that have been observed to 
phagocytose  previously (223) and in experiments described in this chapter (Figures 4.1-
4.2, 4.6) but that do not do so significantly more than other lymphocytes (Figure 4.8). 
In conclusion, in all donors tested CD3+ γδ TCR+ cells with the normal morphology of a 
T cell could be found with phagocytosed bacteria clearly evident inside the cytoplasm. 
However, a majority of the phagocytic CD3+ γδ TCR+ cells did not have lymphocyte 
morphology. These results can be interpreted in two ways. They either suggest the purity 
of the sort was very low, with over 40% contaminating granulocytes, or, alternatively, that 
a CD3/γδ TCR complex is indeed expressed in a fraction of polymorphonucleated cells. 
Both possibilities were addressed and are shown in detail in the following sections. 
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Figure 4.13 – Phagocytosing CD3+ γδ TCR+ cells in whole blood have unusual 
morphology 
Comparison between the morphology of phagocytic and non-phagocytic CD3+ γδ TCR+ cells 
isolated by FACS sorting from whole blood incubated with opsonised GFP-expressing E. coli. 
FACS sorted fractions were cytospun onto slides and stained with Diff-Quick. The nucleus stains 
darker than the cytoplasm highlighting nuclear morphology. Bacteria are apparent as dark dots in 
the cytoplasm. (A) Cells from the non-phagocytic fraction. (B) to (J) Cell from the phagocytic 
fraction. All cells were scored according to size and nuclear morphology. Plots show average of 3 
independent donors. PMN= polymorphonucleated cell. (K) Non-phagocytic fraction. (L) 
Phagocytic fraction. 
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4.11 Purity assessment of FACS sorted fractions of CD3+ γδ TCR+ cells 
In order to characterise phagocytic CD3+ γδ TCR+ cells present in whole blood, the assay 
described in section 4.8 was performed followed by FACS sorting of the GFP+ CD3+ γδ 
TCR+ and GFP- CD3+ γδ TCR+ fractions. The FACS sorted fractions were then tested 
for ROS production (Figure 4.11) or inspected using histological stains (Figure 4.13). The 
purity of the sort was assessed by running a small sample of unsorted and FACS sorted 
cells through a flow cytometer immediately after the sort. 
The normal range of γδ T cells in healthy adults is 55 000 – 120 000 γδ T cells per ml of 
blood. This range is taken from T cell phenotyping studies in a large cohort of 352 
peripheral blood samples (294). Assuming an average frequency of phagocytosis of 
approximately 10% of γδ T cells (Figure 4.9), I would expect to recover around 5 000 to 
10 000 phagocytic γδ T cells per 1 ml blood sample tested. However, FACS sorting is less 
efficient at isolating very rare subsets of cells (295) and the number of cells actually 
recovered was somewhat smaller averaging around 10 000 non-phagocytic CD3+ γδ 
TCR+ cells and 300-500 phagocytic CD3+ γδ TCR+ cells per 1 ml blood sample tested. 
In order to ensure that sufficient cells of the phagocytic fraction would be available for the 
experiments for which they were being FACS sorted (the NBT test or the histological 
staining), the purity of the sort was always assessed using a sample from the non-phagocytic 
fraction, as both samples were FACS sorted simultaneously from the same sample. 
In addition, it should be noted that in the earlier quantification experiments, PE was 
deliberately avoided because of the known spectral overlap with GFP fluorescence. 
However, the FACS sorting machine available has a smaller range of lasers than the LSRII 
flow cytometer used for sample analysis and because of this the fluorochromes eFluor450 
and APC used in the initial quantification experiments were replaced with PE and APC for 
the characterisation experiments that followed. Therefore, before FACS sorting, 
compensation was set using a GFP single stained control. 
Figure 4.14 shows an example of the proportion of CD3+ γδ TCR+ cells before and after 
FACS sorting. The unsorted cells were used to draw a generic cell gate by FSC x SSC and 
then a second CD3+ γδ TCR+ region gated on the cell gate. The graph underneath shows 
the purities of the individual experiments depicted in Figures 4.11 and 4.13. The purity as 
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measured by the proportion of CD3+ γδ TCR+ cells in the collected non-phagocytic 
fraction was very high with an average of 97.30% CD3+ γδ TCR+ cells. 
In one donor a sample containing 192 phagocytic CD3+ γδ TCR+ cells was also tested for 
purity in parallel with the non-phagocytic fraction. The results are shown in Figure 4.15. 
The purity of the two fractions was very different, even though they were isolated from 
exactly the same sample simultaneously. The sorted non-phagocytic CD3+ γδ TCR+ 
fraction showed a high purity of 98.83% CD3+ γδ TCR+ cells (Figure 4.15B) and these 
cells were completely negative for GFP (Figure 4.15C). Surprisingly only 6.25% of cells in 
the sorted phagocytic CD3+ γδ TCR+ fraction were CD3+ γδ TCR+ cells, as assessed by 
flow cytometry immediately after the sort (Figure 4.15D). The majority of the 
contaminating cells (54.69%) were CD3- cells with high fluorescence in the PE channel. 
Compensation was set before the sort with a GFP single stained control. Therefore, high 
fluorescence in the PE channel should not be a result of “fluorescent spillover” of the GFP 
fluorescent cells into the PE channel. However, high autofluorescence is a characteristic of 
granulocytes, particularly eosinophils (296), and hence these cells may appear PE+. In fact, 
autofluorescence alone has been used by some researchers as a tool to FACS sort unstained 
eosinophils (297). The remaining contaminants in the phagocytic CD3+ γδ TCR+ fraction 
appeared to be αβ T cells (CD3+ γδ TCR-) that were surprisingly present in greater 
numbers (39.06%) than CD3+ γδ TCR+ cells (6.25%). Therefore, the phagocytic FACS 
sorted fraction was composed of CD3+ γδ TCR+ cells, CD3+ γδ TCR- cells and CD3- γδ 
TCR- cells (Figure 4.15D). 
Further analysis of the phagocytic FACS sorted fraction (Figure 4.15E) revealed that it 
contained both GFP+ and GFP- cells. Plotting each of the populations apparent in the 
CD3 x γδ TCR dot plot (Figure 4.15D) on a GFP histogram revealed that CD3+ γδ TCR+ 
cells displayed a small GFP-E. coli+ peak, CD3+ γδ TCR- cells were negative for GFP and 
CD3- γδ TCR- cells were almost all positive for GFP (Figure 4.15F). By plotting all the 
individual 192 cells from the phagocytic CD3+ γδ TCR+ fraction in a GFP x CD3 dot 
plot it is clear that the contaminating αβ T cells were non-phagocytic, the majority (all 
except 8 out of 103 cells) of contaminant CD3/γδ TCR double negative cells were 
phagocytic and 1 out of a total of 12 true CD3+ γδ TCR+ cells was phagocytic (Figure 
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4.15G). Clearly, many phagocytic cells that are not γδ T cells are present in the sorted 
fraction. However, the low number of γδ T cells present in this sample (12 cells) makes it 
difficult to determine whether or not this population is significantly phagocytic. 
Earlier in this chapter, I presented microscopy evidence of phagocytosis in γδ T cells 
isolated from PBMCs. However, the frequency of phagocytosis by these γδ T cells was not 
significantly different from that of other lymphocytes tested and was very small. When 
testing whole blood, γδ T cells appeared to be significantly more phagocytic that other 
lymphocytes. These cells were able to produce reactive oxygen species following 
phagocytosis. However, many of these cells had a granular appearance by flow cytometry 
light scatter and were polymorphonucleated. In addition, testing the purity of the FACS 
sorted fractions by re-running them in a flow cytometer revealed a high purity of γδ T cells 
in the non-phagocytic fraction and a low purity in the phagocytic fraction, even though 
these were both sorted simultaneously from the same sample. It may be that the fact that 
phagocytic γδ T cells seemed to be 10-fold rarer than their non-phagocytic counterparts 
amplifies the effect of any error during sorting. For example, if 1 cell out of every 106 in 
the sample is incorrectly sorted into one of the collection wells it will have a 
disproportionally higher effect on the phagocytic γδ T cell fraction. This is because the 
incorrectly sorted cells will be diluted out by the non-phagocytic γδ T cells (total number 
of cells in fraction around 104) much more than in the phagocytic γδ T cell fractions (total 
number of cells in fraction around 300-500). 
An alternative explanation for the presence of granulocytes in FACS sorted phagocytic 
CD3+ γδ TCR+ fractions could be the presence of granulocytes expressing a CD3/γδ 
TCR complex in whole blood. Experiments to test for their presence are described in the 
following section. 
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Figure 4.14 – Purity assessment of FACS sorted γδ T cells by flow cytometry 
Purity assessment of the FACS sorted cells used in the experiments shown in Figure 
4.11 and Figure 4.13. A sample of cells was taken from the FACS sorted GFP- CD3+ 
γδ TCR+ cells and immediately tested for purity by flow cytometry in all five assays. 
Representative plots from one experiment are shown. A graph with purity results for 
all the experiments is shown. 
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Figure 4.15 – Purity of non-phagocytic and phagocytic FACS sorted γδ T cells 
Non-phagocytic and phagocytic fractions of γδ T cells were sorted simultaneously from the same sample 
for the assays described in Figure 4.11 and 4.13. Purity was routinely assessed using the non-phagocytic γδ 
T cell fraction due to the scarcity of the phagocytic fraction. To test whether the purity of one fraction 
could be used as a surrogate for the other, a sample containing 192 phagocytic CD3+ γδ TCR+ cells was 
tested for purity in one experiment. (A) Dot plot showing CD3 x γδ TCR fluorescence in the original 
sample. (B) Purity of the non-phagocytic fraction by CD3 x γδ TCR dot plot and (C) GFP histogram. (D) 
Purity of the phagocytic fraction by CD3 x γδ TCR dot plot. 3 separate cell populations are evident. (E) 
Phagocytic fraction GFP histogram. (F) GFP histogram gated on the 3 separate populations shown in (D). 
(G) GFP x CD3 dot plot for the 3 populations gated in (D). 
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4.12 The γδ TCR is not expressed on polymorphonucleated fractions in whole 
blood 
Recent studies in myeloid immune cells have challenged the dogma that rearranged T cell 
receptors are an exclusive feature of T cells. Puellmann and colleagues demonstrated that 
a proportion of peripheral blood neutrophils from healthy humans express rearranged T 
cell receptors (291). On average, 5-8% of neutrophils in circulation were found to express 
variable immune receptors composed of α and β TCR chains. They also reported the 
presence of γ and δ TCR chains in bulk neutrophil preparations by RT-PCR and Western 
blot. However, what researchers commonly refer to as “neutrophil preparations” are 
actually the polymorphonucleated cell fractions (PMN) of blood samples. The method 
Puellmann et al used is commonly found in neutrophil literature and involves an initial 
dextran sedimentation step to remove RBC followed by a density gradient centrifugation 
step which separates PBMC and PMN fractions. Because neutrophils are by far the most 
common type of leukocyte present in the blood (50 to 70% of total leukocytes) they will 
constitute the vast majority of cells in PMN fractions. However, other granulocytes may 
also be present. Although eosinophils (1 to 3% of leukocytes) and basophils (0.5 to 1% of 
leukocytes) are rare when expressed as a percentage of total leukocytes, they will be 
enriched in PMN fractions. Accordingly, when Legrand et al replicated this work but 
additionally separated the granulocyte fractions into CD16+ (neutrophils and basophils) 
and CD16- (eosinophils), they found only the eosinophil fractions expressed a CD3/γδ 
TCR complex (292). 
I investigated the presence of a CD3/γδ TCR complex in PMN fractions by flow cytometry 
in two different donors and Western blot in one additional donor. For flow cytometry, a 
blood sample was freshly drawn and stained for CD3, γδ TCR and CD16. Granulocytes 
have a high refractive index due to the abundance of intracellular granules and consequently 
exhibit high side scatter (SSC) profiles evident by flow cytometry. A scatter plot of a fresh 
blood sample lysed for red blood cells will typically distinguish lymphocyte, monocyte and 
granulocyte populations (Figure 4.16A). I gated on lymphocytes and then on CD3+ cells 
to draw a CD3+ γδ TCR+ gate. In addition, neutrophil and eosinophil populations were 
gated based on expression of CD16 together with high SSC (Figure 4.16D) as previously 
described (298). 
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Gated neutrophils (Figure 4.16E) and eosinophils (Figure 4.16F) had no significant 
expression of CD3 and γδ TCR, as defined previously with T cells in the lymphocyte gate. 
This was true for both donors tested with an average CD3+ γδ TCR+ of 0.29% for 
neutrophils and 0.64% for eosinophils. Interestingly, a small number of neutrophils but 
not eosinophils seemed to be CD3+ γδ TCR- perhaps corresponding to the αβ TCR+ 
neutrophils reported previously by Puellmann (291).  
Intracellular staining of whole blood was not informative due to high unspecific 
fluorescence and the fact that permeabilising cells changes their light scatter profile (data 
not shown). Eosinophil cytoplasmic granules in particular are known to strongly bind some 
fluorescent molecules like FITC (299). In addition, unstained eosinophils exhibit unusually 
high autofluorescence due to the presence of native fluorescent intracellular flavins which 
are excited by blue-green light and emit over a broad range of wavelengths (297). High 
eosinophil autofluorescence is evident in Figure 4.16F. This property alone has been 
exploited in the past to FACS sort unstained eosinophils (297). 
In previous experiments, highly autofluorescent granulocytes appeared to have been 
incorrectly FACS sorted into the phagocytic CD3+ γδ TCR+ fractions leading to 
polymorphonucleated cells making up over 40% of phagocytic FACS sorted fractions 
(Figure 4.13). However, in the experiments described in this section no significant 
expression of CD3 and γδ TCR was detected in neutrophils and eosinophils. Two other 
effects possibly worked together to result in a low purity specifically in the FACS sorted 
phagocytic γδ T cell fraction: 
1) Rarity – the rarer the cell type, the lower the purity of the fraction. This is due to 
the cumulative effect of small errors during cell sorting. The order of cell type 
frequency in whole blood is: granulocytes > αβ T cells > monocytes ≈ NK cells > 
γδ T cells > phagocytic γδ T cells. 
2) Granulocytes autofluorescent in the CD3 and γδ TCR channels will tend to be 
GFP+ as they will be strongly phagocytic for GFP-E. coli. Therefore, they will 
preferentially be sorted into the phagocytic CD3+ γδ TCR+ fraction as opposed to 
the non-phagocytic CD3+ γδ TCR+ fraction. 
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A possible solution to the problem of incorrectly FACS sorting granulocytes into the 
phagocytic γδ T cell fraction could be to repeat the same assay using CD15 to exclude 
granulocytes from the γδ T cell gate. CD15 is expressed on neutrophils, eosinophils and 
monocytes. However, although not usually found on T cells, it can be expressed on late 
stage activated T cells (300) and so could potentially also exclude phagocytic γδ T cells. A 
better solution would be to repeat these experiments using PBMC fractions from healthy 
donors since these typically contain no granulocytes. This approach would be necessary to 
validate the results in Figure 4.9 that showed that an average of 12% of γδ T cells in the 
blood (range 5.00% to 21.32%) phagocytosed opsonised E. coli. 
Finally, even though CD3/γδ TCR complexes could not be found on the surface of 
neutrophils or eosinophils, it is still conceivable that intracellular stores of these markers 
could be mobilised to the cell surface during the bacterial assay. To investigate whether 
intracellular γδ TCR is present in polymorphonucleated cells, PMN and PBMC fractions 
were isolated from one donor (Figure 4.17). Diff-Quick staining of the PMN fraction 
demonstrated that the fraction was rich in neutrophils, identified by their multilobed “C-
shaped” nuclei and light cytoplasm, and eosinophils, with bi-lobed nuclei and strong eosin 
staining. As positive and negative controls for γδ TCR expression, γδ T cells and 
monocytes were purified from PBMC by direct magnetic isolation. γδ TCR expression 
could not be detected in the PMN fraction by Western blot. A strong γδ TCR signal was 
detected in the purified γδ T cells. Curiously, a small γδ TCR signal was also found in 
monocytes isolated with magnetic beads bound to CD14 antibodies as previously reported 
(293). 
In conclusion, I did not find evidence that a CD3/γδ TCR complex is expressed by either 
neutrophils or eosinophils using flow cytometry and Western blot. However, this does not 
exclude the possibility that the strong autofluorescence of these cells caused them to be 
FACS sorted together with true CD3+ γδ TCR+ cells. 
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Figure 4.16 – The CD3/ γδ TCR complex is not expressed in human neutrophils or eosinophils 
Investigation into the possible presence of CD3/γδ TCR expressing granulocytes in whole blood. Whole 
blood was stained with CD3, CD16 and γδ TCR antibodies. The samples were RBC lysed and fixed and 
analysed by flow cytometry. γδ T cells were gated using sequential gating. (A) A generic lymphocyte gate 
was set based on FSC x SSC properties. Activated lymphocytes apparent by FSC x SSC were also included 
in this gate. (B) CD3+ cells in the lymphocyte gate were selected to draw a T cell gate. (C) The cells in the 
T cell gate were plotted on a CD3 x γδ TCR dot plot to draw a CD3+ γδ TCR+ region. This region was 
later used to probe for CD3/γδ TCR expression in granulocyte populations. (D) Dot plot of an ungated 
whole blood sample is used to identify neutrophils and eosinophils based on high SSC and the presence or 
absence of CD16. (E) CD3/ γδ TCR expression in gated neutrophils. (E) CD3/γδ TCR expression in gated 
eosinophils. 
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Figure 4.17 – The γδ TCR is not expressed by polymorphonucleated cells 
Investigation into the possible presence of γδ TCR expressing granulocytes in whole blood. PMN and 
PBMC fractions were isolated from whole blood using dextran and density gradient separations. (A) A 
sample of the PMN fraction was stained with Diff-Quick. Red, eosinophil granules; dark violet, nuclei; pale 
pink, cytoplasm. (B) γδ T cells and monocytes were purified by MACS from PBMC. The cell fractions were 
analysed by Western blot. The membrane was probed for γδ TCR using GAPDH as a loading control. (C) 
A density plot of the bands is shown. 
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4.13 Summary  
 γδ T cell phagocytosis of E. coli was observed by confocal microscopy 
 Fewer than 2% of γδ T cells were identified as phagocytic using a flow cytometry 
assay that discriminates between intracellular and extracellular bacteria. 
 Internalisation of live opsonised E. coli by γδ T cell fractions was detected using a 
gentamicin protection assay. 100 bacteria per leukocyte were needed to detect 
phagocytosis in γδ T cell fractions whereas 1 bacteria per leukocyte was sufficient 
to detect phagocytosis in monocyte fractions tested in parallel. 
 In a blindly-scored confocal microscopy phagocytosis assay, phagocytosis was 
detected in 2.50% of γδ T cells, which was a lower rate than that observed in 
monocytes (59.09%) and not significantly different from αβ T cells (0.75%) and NK 
cells (1.70%). 
 In a whole blood phagocytosis assay by flow cytometry, phagocytosis was detected 
in 12.21% of γδ T cells and was significantly different from αβ T cells (3.85%) and 
NK cells (1.35%). 74.59% of monocytes tested in parallel phagocytosed. 
 GFP-E. coli+ CD3+ γδ TCR+ fractions FACS sorted following a whole blood 
phagocytosis assay produced reactive oxygen species when tested in a NBT assay. 
 Histological staining and light microscopy inspection revealed only 58.33% of GFP-
E. coli+ CD3+ γδ TCR+ fractions FACS sorted following a whole blood 
phagocytosis assay had a mononuclear morphology whereas the remainder were 
polymorphonucleated cells. 
 GFP-E. coli- CD3+ γδ TCR+ fractions could be FACS sorted following a whole 
blood phagocytosis assay to high purity (97.30% CD3+ γδ TCR+) but GFP-E. coli+ 
CD3+ γδ TCR+ fractions FACS sorted simultaneously from the same sample had 
a much lower purity (6.28% CD3+ γδ TCR+) 
 A CD3/γδ TCR complex was not detected in PMN cells by flow cytometry or by 
western blot. 
This chapter described experiments investigating phagocytosis by human blood γδ T cells. 
These experiments aimed to clarify the role that γδ T cell phagocytosis may play in the 
immune response by addressing questions that have not been studied in the field. In 
